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Chronic inflammation is associated with numerous human diseases. During 
inflammation, leukocytes release the enzyme myeloperoxidase (MPO) which generates 
reactive oxygen species such as hypochlorous acid (HOCl). Additionally, MPO generates 
reactive nitrogen species. These reactive species can damage host fats, proteins, and 
DNA, contributing to disease pathology. 
  Because of the reactivity and short half-lives of reactive species, measurement of 
surrogate markers is necessary to determine their extent and source. Chlorination of the 
tyrosine phenol ring by HOCl to produce 3-chlorotyrosine (3ClTyr) or nitration of the 
phenol ring by reactive nitrogen species to produce 3-nitrotyrosine (NO2Tyr) are two 
such markers. Both are stable byproducts of MPO activity and are readily measurable. 
 Some studies, however, have called into question their use as biomarkers of 
inflammation. Concentrations of 3ClTyr or NO2Tyr reportedly decrease upon exposure to 
HOCl, suggesting that any measurement of these in vivo would be underestimated. These 
studies, however, failed to quantify the rate of degradation and did not identify the 
products. 
 Furthermore, there is some evidence to suggest that, in vivo, chlorination of 
tyrosine by HOCl occurs through chloramine intermediates rather than directly. This is 
 xv 
evidenced by the preferential chlorination of tyrosine residues that are nearby lysine or 
histidine, whose side-chain amines react with HOCl to become chloramines. This 
contradicts the relatively slow reactions kinetics of tyrosine chlorination by histidine or 
lysine chloramine and warrants further investigation. 
 In these studies, we identify the product of 3ClTyr and NO2Tyr reacting with 
HOCl as 3,5-dichlorotyrosine (Cl2Tyr) and 3-chloro-5-nitrotyrosine (ClNO2Tyr), 
respectively. The second-order rate constants of the chlorination of tyrosine, 3ClTyr, and 
NO2Tyr by HOCl, histidine chloramine, and lysine chloramine are reported. The 
relevance of Cl2Tyr and ClNO2Tyr in vivo are discussed. 
 Additionally, we investigate the kinetics of tyrosine chlorination in the context of 
a lysine- or histidine-containing peptide. The rate of chlorination of tyrosine within a 
peptide is dependent on the primary and secondary structure and is a first-order, 
intramolecular reaction. These studies further support the role of chloramines in the 
chlorination of protein-bound tyrosine and, to our knowledge, are the first to provide rate 
constants. 
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CHAPTER ONE 
INTRODUCTION 
Inflammation Contributes to Disease Pathology 
Inflammation is a defensive response triggered by damage to living tissues. Its 
purpose is to localize and eliminate any harmful agents and remove damaged components 
so that the body can begin the healing process. However, prolonged periods of 
inflammation can be more harmful than beneficial. Chronic inflammation can eventually 
lead to tissue destruction and the functional impairments that characterize many human 
disease conditions.1 The generation of reactive oxygen species (ROS) in inflammatory 
tissue is thought to drive proinflammatory cytokine production, thus prolonging the 
duration of the inflammatory process and contributing to the pathogenesis of human 
diseases.2 
The human diseases that are associated with chronic inflammation and reactive 
oxygen species are varied, affecting numerous organ systems with different presentations. 
Chronic inflammation has been implicated in the pathology of disorders including 
psoriasis of the skin,3 arthritis of the joints,4 lung diseases,5-7 cardiovascular disease,8-10 
and neurodegenerative diseases.11-13 Even cancers are associated with chronic 
inflammation, as seen in the increased incidence of colorectal cancer in patients with 
inflammatory bowel disease,14, 15 increased production of reactive species in breast 
tumors,16, 17 and  studies linking inflammation with tumorigenesis.18-21 As reactive species 
have been implicated in more and more disease pathologies, there has been a greater 
effort to study their generation and to measure their effects in tissue. 
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Myeloperoxidase Creates Chlorinating and Nitrating Species 
 Neutrophils are a major source of reactive oxygen species and are likely 
contributors to the diseases in which inflammatory cells participate.22 Neutrophils that 
have been activated by cytokines during inflammation generate superoxide and its 
dismutase byproduct, hydrogen peroxide. In addition, the heme enzyme myeloperoxidase 
(MPO) is released which has the unique ability to catalyze the reaction between chloride 
ions and hydrogen peroxide to create hypochlorous acid (HOCl).23 
 HOCl is a highly reactive species that can react to form either oxidized or 
chlorinated products. In vivo, there are many potential targets of HOCl including nucleic 
acids, lipids, and proteins.24, 25 Reactions with proteins are especially common due to 
their relative abundance. HOCl reacts rapidly with thiols or thioesters on cysteine or 
methionine side-chains,26 with free amines on the N-terminus or lysine and histidine side-
chains to give chloramines,27 and with the phenol ring of tyrosine producing 3-
chlorotyrosine (3ClTyr).28 These reactions damage proteins thus impairing their normal 
function.29 For example, apolipoprotein A-I, which normally removes cholesterol from 
macrophages, can by oxidized by HOCl, impairing its ability to remove cholesterol and 
contributing to atherosclerosis of arteries.30 
In addition to oxidation and chlorination, MPO participates in the generation of 
reactive nitrating agents. Two such species are nitrogen dioxide (NO2
•), which is 
generated by the oxidation of nitrite (NO2
-) by MPO,31 and nitryl chloride (NO2Cl2), 
which is generated by the oxidation of NO2
- by MPO-derived HOCl.32, 33 These reactive 
nitrogen species can result in modulation of the catalytic activity of enzymes through 
nitration. For example, nitration of cyclooxygenase-2 results in inhibition, shortening the 
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inflammatory response,34 or nitration can inhibit mitochondrial respiration, leading to cell 
death.35-37 Nitration of tyrosine by NO2Cl or NO2
• results in the formation of 3-
nitrotyrosine (NO2Tyr). Figure 1 provides a summary of reactions involving MPO that 
results in the generation of reactive nitrogen species and ROS. 
 
Tyrosine Analogues as Markers of MPO Activity 
Biomarkers of reactant species have the potential to allow researchers and 
clinicians the ability to determine the extent of oxidative injury and identify the source of 
the oxidative stress. Unfortunately, finding an appropriate biomarker can be challenging. 
Expression of MPO, for example, has been correlated to disease pathology,38-40 but its use 
as a potential biomarker of reactive species is complicated by the presence of both active 
and inactive forms of the enzyme.41-43 Direct measurement of oxidative species 
themselves is also difficult because of their high reactivity and short lifetime in biological 
environments.44 Instead, surrogate markers, often the product of a reactive species with a 
biological molecule, need to be measured to study the role of reactive species in disease 
pathology.45, 46 
The characteristics of a good biomarker include specificity, stability, and 
measurability.24 Specificity means that the marker is only produced by the reactive 
species or enzyme in question. For example, MPO is the only human enzyme to produce 
HOCl and is present predominantly in neutrophils and monocytes.47 Thus, HOCl or 
HOCl-derived byproducts would be specific markers of the oxidant activity of 
neutrophils and other MPO-containing cells. 
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Figure 1: Potential Pathways of Tyrosine Chlorination and Nitration by MPO. Cl‒, 
chloride; H2O2, hydrogen peroxide; HOCl, hypochlorous acid; iNOS, inducible nitric oxide 
synthase; MPO, myeloperoxidase; NO•, nitric oxide; NO2
•, nitrogen dioxide; NO2
‒, nitrite; 
NO2Cl, nitryl chloride; O2
•
, superoxide; ONOO
‒, peroxynitrite. 
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Stability implies that a molecule is able to persist for great lengths of time in 
physiologic conditions, without degrading further, reacting with other molecules, or 
being enzymatically repaired. DNA bases, for instance, are oxidized or chlorinated by 
HOCl to form hydroxyuracil, 5-hydroxycytosine, 8-chloroadenosine, 5-chlorocytosine, 
and more.48-50 However, the repair of damaged DNA molecules, with the possible 
exception of 5-chlorocytosine,51 precludes their use as biomarkers of HOCl. 
Chloramines, the byproduct of HOCl with free protein amines, also continue to react with 
other molecules at high rates and have relatively short half-lives.52, 53 Chlorination or 
nitration of tyrosine by MPO-derived compounds to make 3ClTyr or NO2Tyr, however, 
produce more stable end products that persist for long periods of time in vivo.54, 55 
 Measurability of a potential biomarker means that there are laboratory techniques 
or instruments to measure the marker that are consistent and sensitive. In the case of 
3ClTyr and NO2Tyr, several methods of measuring these compounds exist. 3ClTyr can 
be measured qualitatively by antibody-based immunoassays56, 57 or quantitatively 
measured by mass spectrometry58 and HPLC.59 NO2Tyr can likewise be measured using 
HPLC60 and tandem mass spectrometry,61, 62 while its measurement by immunoassays is 
still undergoing investigation.63 Because they are unique byproducts of MPO activity, 
stable, and quantifiable, both 3ClTyr and NO2Tyr are promising potential biomarkers of 
the extent of MPO activity in inflamed tissue.  
 
The Purpose of These Studies 
While much of the literature appears to support the role of 3ClTyr and NO2Tyr as 
biomarkers of MPO in inflamed tissue, two studies in particular have called into question 
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their stability and usefulness as biomarkers. One study qualitatively describes the loss of 
measureable 3ClTyr upon exposure to HOCl.59 Likewise, the second study shows 
concentrations of NO2Tyr decrease when exposed to HOCl.
64 These studies suggest a 
more complicated relationship with HOCl and implicate that these markers have been 
underestimated in previous reports. Neither of these studies, however, quantitatively 
measured the rate of disappearance nor suggested what the products of such a reaction 
would be. 
In addition, it has been suggested by other studies that, in vivo, tyrosine is more 
likely to be chlorinated by HOCl-derived chloramines than by HOCl directly.44, 47 Even 
though the rate of tyrosine chlorination by lysine chloramine as free amino acids appears 
too slow to be of significance,65 several different groups have shown preferential 
chlorination of tyrosine residues within proteins that are near in space to histidine or 
lysine residues.55, 65, 66 Though this pattern has been established, there have been no 
studies into the exact mechanism of tyrosine chlorination in this context nor the 
quantification of the rates of chlorination. 
Our purpose in these studies is to investigate the disappearance of 3ClTyr and 
NO2Tyr on exposure to HOCl, to determine what role chloramines play in tyrosine 
chlorination, and to investigate how tyrosine chlorination differs in the context of a 
peptide. Our first study identifies the product of 3ClTyr reacting with HOCl, measures 
the rate at which 3ClTyr disappears, and shows how lysine and histidine chloramines are 
able to accomplish tyrosine chlorination as well, albeit slower than HOCl (Chapter 2).  
The second study focuses on the disappearance of NO2Tyr when it reacts with HOCl, 
again investigating the role of chloramines, but this study further investigates the 
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mechanism of how chloramines are able to more favorably chlorinate tyrosine when they 
are located on the same peptide (Chapter 3). Our last study looks at how changes in the 
primary or secondary structure of a peptide that place tyrosine and chloramine residues 
closer in space are able to change the reaction kinetics, significantly speeding up the rate 
of chlorination when compared to free amino acids (Chapter 4). Finally, our conclusions 
are summarized and the relevance of our findings in regards to the role of 3ClTyr and 
NO2Tyr as biomarkers of MPO activity are discussed in the context of our current 
understanding of the literature (Chapter 5). 
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Abstract 
 The persistent activation of innate immune cells in chronic inflammation is 
gaining recognition as a contributing factor in a number of human diseases. A 
distinguishing feature of activated leukocytes at sites of inflammation is their production 
of reactive species such as hypochlorous acid (HOCl). Investigating the role of reactive 
molecules like HOCl in inflammation and human disease requires appropriate 
biomarkers. The preferred biomarker for HOCl, and by extension its synthesizing enzyme 
myeloperoxidase, is 3-chlorotyrosine. 3-Chlorotyrosine is a chemically stable product 
formed when HOCl, or a HOCl-induced chloramine, reacts with the tyrosine side-chain 
and is readily measured by sensitive mass spectrometry methods. However, Whiteman 
and Spencer1 recently noted that 3-chlorotyrosine is degraded by HOCl, calling into 
question its use as a biomarker. The kinetic rate constants of HOCl, histidine chloramine, 
and lysine chloramine reacting with 3-chlorotyrosine to form 3,5-dichlorotyrosine are 
reported. The kinetics of tyrosine chlorination in the context of a peptide with a nearby 
lysine residue was also determined and further supports the role of chloramines in the 
chlorination of protein-bound tyrosine residues. The likelihood of free 3,5-
dichlorotyrosine occurring in vivo, given the reported rate constants, is discussed. 
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Introduction 
The persistent activation of innate immune cells in chronic inflammation is 
gaining recognition as a contributing factor in numerous human diseases including 
diabetes, neurodegeneration, atherosclerosis, and cancer.2-7 The reactive species 
superoxide, hydrogen peroxide, hypochlorous acid (HOCl), and hypobromous acid are 
generated by human leukocytes.8 Myeloperoxidase (MPO), found in neutrophils, 
monocytes, and macrophages, generates HOCl using hydrogen peroxide to oxidize 
chloride ions.9 While HOCl kills invading microorganisms, it is also toxic to host cells.10, 
11 These reactive species, produced at sites of inflammation, are thought to contribute to 
the pathology of human disease.12  
 However, the direct measurement of HOCl is not feasible because of its reactivity 
and short half-life in biological environments.13 While expression of MPO correlates with 
pathologies including cardiovascular disease,14, 15 cancer,7, 16 and neurodegenerative 
disease,17-19 measurement of MPO as a biomarker for reactive species is complicated by 
the presence of both active and inactive forms of the enzyme.20-22 The products that result 
when reactive species damage biological molecules are instead used as surrogate markers 
to investigate the role of reactive species in disease pathology.23,24  
 Surrogate markers of HOCl result from the reaction of HOCl with nucleic acids, 
proteins, and lipids.25 HOCl oxidizes DNA bases forming 5-hydroxyuracil, 5-
hydoxycytosine, and thymine glycol.26 HOCl can also chlorinate DNA forming 8-
chloroguanosine, 8-chloroadenosine, and 5-chlorocytosine.27 HOCl-generated DNA 
damage will result in mutations if not repaired.28, 29 However, the repair of damaged 
DNA, with the possible exception of 5-chlorocytosine,30 likely precludes the use of these 
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HOCl damage products as a biomarker of HOCl. Furthermore, DNA and lipid oxidation 
or chlorination are slower than the reactions of HOCl with protein side-chains suggesting 
that protein damage will reach higher concentrations in vivo.31-34 
Products of both oxidation and chlorination damage occur when proteins or amino 
acids are exposed to HOCl.35 The preferred marker of HOCl in vivo is 3-chlorotyrosine 
(3ClTyr); a stable and unique product qualitatively measured by antibody-based 
methods36, 37 or quantitatively measured by mass spectrometry.38 As most tyrosine is 
incorporated into cellular proteins, in vivo measurements of 3ClTyr focus on protein-
bound tyrosine and 3ClTyr. Measurements of 3ClTyr in human tissues were found to 
correlate with other measurements of disease.39-41 Given the clinical connection between 
inflammation and human diseases, researchers will continue to use 3ClTyr as a biomarker 
to determine the role of HOCl in the etiology of these diseases. 
The reported kinetics of tyrosine chlorination by HOCl is slow relative to the rate 
of reaction with other protein side-chains.31 The observation of 3ClTyr in vivo indicates 
that HOCl was formed in sufficient quantities to chlorinate tyrosine despite the slow rate 
measured in vitro. However, Whiteman and Spencer report that 3ClTyr is lost when 
exposed to HOCl suggesting a more complicated relationship between HOCl and 3ClTyr, 
calling into question the use of 3ClTyr as a biomarker.1 Previous articles suggested that 
3ClTyr reacts with HOCl to form 3,5-dichlorotyrosine (Cl2Tyr).
42-46 However, the 
kinetics of HOCl reacting with 3ClTyr is not known nor did the above cited papers 
attempt to measure Cl2Tyr in vivo. In this study we report the kinetics of 3ClTyr 
chlorination to form Cl2Tyr. 
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Our early experiments also noted a discrepancy with the previously reported 
model used to calculate the kinetics of tyrosine chlorination; the appearance of UV/Vis 
absorbance bands at 240 and 300 nm was observed and attributed to an intermediate 
product preceding formation of 3ClTyr.31 However, we have observed that authentic 
samples of Cl2Tyr, not 3ClTyr or some unknown intermediate, contain UV/Vis 
absorption peaks near 240 and 300 nm indicating the formation of Cl2Tyr during the 
experiments reported to measure the chlorination of tyrosine to form 3ClTyr. 
Furthermore, the buffer used in this previous study lacked chloride ions raising the 
concern that their reported rate constants may not reflect the physiological rate if chloride 
ions participate in the chlorination reaction. In this study we used an HPLC method and 
authentic standards to remove ambiguity when determining the kinetics of tyrosine and 
3ClTyr chlorination by HOCl and determined the impact of chloride ions on the kinetics 
as a function of pH.  
One solution to the slow rate of direct chlorination of tyrosine by HOCl is the 
suggestion that the rapid chlorination of a lysine residue or N-terminal amino group to 
form a chloramine will in turn rapidly chlorinate a nearby tyrosine residue.44, 47 However, 
Pattison and Davies found that the chloramine of a lysine side-chain analogue very 
slowly chlorinated tyrosine over nine days with low levels of chlorine incorporation.48 In 
this study, we examine the kinetics whereby lysine chloramines chlorinate tyrosine 
residues, both as individual amino acids and in the context of a polypeptide using mass 
spectrometry to characterize the peptide products following reaction with HOCl. 
At this time, an accurate estimate of the physiological quantities and 
concentrations of HOCl reached in vivo is missing. The relative kinetics of reactions 
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between HOCl and biological molecules is important for defining the normal and 
pathological ranges of HOCl production in human tissues. The rate constants of 3ClTyr 
chlorination, we argue, will allow more accurate estimates of HOCl formation in vivo.  
 
Experimental Procedures 
Materials 
 L-Tyrosine, N-acetyl-L-tyrosine (AcTyr), N-α-acetyl-L-lysine (AcLys), and N-
acetyl-L-histidine (AcHis) were purchased from Novabiochem (San Diego, CA). 
Fluorenylmethyloxycabonylchloride (FMOC)-amide resin was purchased from Applied 
Biosystems, Inc. (Foster City, CA). FMOC-Lys(BOC)-OH, and all other FMOC-amino 
acids were purchased from Advanced ChemTech (Louisville, KY). α-Cyano-4-
hydroxycinnamic acid matrix and peptide calibration standards were purchased from 
Bruker (Billerica, MA). Sodium hypochlorite, 3-chloro-L-tyrosine, L-methionine, N-
acetylglycine, N-acetyl-L-alanine, N-acetyl-L-glutamic acid, N-α-acetyl-L-asparagine, 
and all other laboratory chemicals were purchased from Sigma-Aldrich (St. Louis, MO).  
 
Synthesis of N-acetyl-3-chlorotyrosine 
3-Chloro-L-tyrosine (1 g, 4.6 mmol) was acetylated with excess acetic anhydride 
(4 ml, 42 mmol) in 100 ml acetone at room temperature (Figure 1). The crude product 
containing N,O-diacetyl-3-chlorotyrosine was formed after reacting overnight and is 
soluble in acetone. The acetone was removed using rotary evaporation after filtering off 
any remaining insoluble impurities. Remaining acetic anhydride was hydrolyzed by 
addition of water. The phenol acetate ester was rapidly hydrolyzed for one hour by 
addition of 1M NaOH until the solution pH was between 8 and 9 resulting in the  
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A. Synthesis of Ac3ClTyr 
 
B. Synthesis of AcCl2Tyr 
 
Figure 1: Synthesis of Ac3ClTyr and AcCl2Tyr. Ac3ClTyr was synthesized by 
acetylation of 3ClTyr with excess acetic anhydride (Ac2O) (A). AcCl2Tyr was synthesized 
by chlorination of tyrosine with excess sulfuryl chloride (SO2Cl2) with subsequent 
acetylation with excess Ac2O (B). 
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formation of N-acetyl-3-chlorotyrosine (Ac3ClTyr) in high purity (> 95% pure). The 
aqueous solution was acidified to a pH < 2 with concentrated hydrochloric acid and then 
added to a SupelClean, LC-18 packing, solid phase extraction (SPE) column (Supelco, 
Bellefonte, PA). Following washing with aqueous 0.1% trifluoroacetic acid (TFA), the 
desired compound was eluted with 5-10% methanol, 0.1% TFA solution. Fractions of ≥ 
98% purity, as determined by analytical HPLC, were dried by vacuum centrifugation and 
stored for later use. The compound gave the expected UV/Vis absorbance maximum at 
279 nm.49 1H-NMR (500 MHz, DMSO-d6), δ: 9.79 (s, 1H, –OH), 8.17 (d, J = 8.1 Hz, 1H, 
NH), 7.16 (d, J = 1.8 Hz, H2), 6.98 (dd, J = 1.8, 8.3 Hz, 1H, H6), 6.86 (d, J = 8.3 Hz, 1H, 
H5), 4.33 (m, 1H, J = 5.0, 8.3, 9.5 Hz, H), 2.92 (dd, 1H, J = 5.0, 13.9 Hz, H), 2.72 (dd, 
J = 9.5, 13.9 Hz, H), 1.79 (s, 3H, CH3). 
 
Synthesis of N-acetyl-3,5-dichlorotyrosine 
The procedure of Allevi et al. was used to synthesize 3,5-dichlorotyrosine 
(Cl2Tyr) from tyrosine, which was then used without further purification.
50 Cl2Tyr was 
acetylated as described above for the acetylation of 3ClTyr (Figure 1). The desired 
compound eluted from the C18 SPE column with a solution consisting of 20% methanol 
and 0.1% TFA. The UV/Vis spectrum in 0.1 M HCl showed the expected absorbance 
maximums at 281 and 287 nm.49 1H-NMR (500 MHz, DMSO-d6), δ: 9.94 (s, 1H, –OH), 
8.15 (d, J = 8.2 Hz, 1H, NH), 7.21 (s, 2H, H2,6), 4.36 (m, J = 5.0, 8.2, 9.5 Hz, 1H, H), 
2.94 (dd, J = 5.0, 13.8 Hz, 1H, H), 2.73 (dd, J = 9.5, 13.8 Hz, H), 1.78 (s, 3H, CH3). 
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Synthesis of Ac-KGNYAE-NH2 
A small peptide, Ac-KGNYAE-NH2, was synthesized using solid phase synthesis 
and fast FMOC chemistry on an Applied Biosystems (Foster City, CA) 433A peptide 
synthesizer. The sequence of this peptide is identical to residues 36 to 41 of human 
histone H2A. We used an FMOC-amide resin and FMOC-protected amino acids with the 
lysine side-chain protected by a tert-butyloxycarbonyl (BOC) protecting group. After 
synthesis, the N-terminal FMOC-group was removed with piperidine and acetylated by 
acetic anhydride and triethylamine in dimethylformamide. The peptide was cleaved from 
the resin and purified by HPLC as previously described.43 Following purification, the 
peptide was characterized by MALDI-TOF in positive-ion mode and determined that the 
peptide monoisotopic mass (M+H+) was 722.34 m/z; the expected monoisotopic mass is 
722.35 m/z. The purity of the peptide was determined to be > 97% by analytical HPLC. 
 
Methods 
 Sodium hypochlorite was stored at 4 °C. The pKa of HOCl is 7.5 resulting in 
equal concentrations of hypochlorous acid and its conjugate base, hypochlorite, at 
physiological pH. The term “hypochlorous acid” is thus used in this article to refer to 
both the acid and its conjugate base. The concentration of the HOCl stock was 
determined daily using the absorbance at 292 nm (292 nm = 350 M-1cm-1) for a fresh 
dilution of the stock into 0.1 M NaOH.51 Dilutions of the HOCl stock were then made 
into buffer. All reactions were initiated by the addition of HOCl and quenched by adding 
10-fold excess methionine, which reacts rapidly with HOCl (~108 M-1s-1).31  
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Tyrosine analogues with acetylated amine groups were used to avoid reaction 
with HOCl forming a chloramine with subsequent degradation to aldehyde products.45 
AcTyr, Ac3ClTyr, and N-acetyl-3,5-dichlorotyrosine (AcCl2Tyr) in 0.1 M HCl displayed 
UV/Vis absorbance’s maximums at 274, 279, 287 nm with molar absorptivity values of 
ε274 nm = 1368 M-1 cm-1, ε279 nm = 1879 M-1 cm-1 and ε287 nm = 1424 M-1 cm-1, 
respectively.49  
 
UV/Vis Spectroscopy of Tyrosine Chlorination by HOCl 
The UV-spectra of AcTyr reacting with HOCl was measured on a Varian (Palo 
Alto, CA) Cary 100 Bio UV-Visible Spectrophotometer in a 1-cm micro quartz cell. 350 
µM Ac3ClTyr and 70 – 350 µM AcTyr were reacted with 200 µM HOCl at room 
temperature and the spectra between 230 and 350 nm was measured every 22 seconds. 
 
Reactions of Tyrosine Analogues with HOCl or Chloramines 
Like previously published kinetics reports, all reactions were buffered with 100 
mM phosphate buffer.31, 48 Most reactions added 200 M HOCl to concentrations 
between 300 and 1500 M of AcTyr, Ac3ClTyr, and AcCl2Tyr. Reactions with N-
acetylhistidine chloramine (AcHisCl) and N--acetyllysine chloramine (AcLysCl) were 
done by premixing tyrosine analogues with excess AcHis or AcLys and then adding 200 
µM HOCl for a final concentration of 1000 µM AcHis or AcLys. Reactions with N--
acetyllysine dichloramine (AcLysCl2) were done by premixing AcLys with tyrosine 
analogues and then adding 200 µM HOCl for a final concentration of 105 µM AcLys. 
Reaction times between 1 and 120 seconds were mixed using a KinTek RQF-3 Rapid 
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Quench Flow apparatus (Austin, TX) maintained at 37 °C while manual mixing was used 
for reaction times longer than 15 seconds in an aluminum block maintained at 37 °C. The 
sample, reaction, and exit loops of the KinTek Quench Flow system were calibrated 
using a solution of AcTyr with known concentration according to the manufacturer’s 
directions. The collected calibration samples were dried by vacuum centrifugation and 
then a known volume of water was added to each sample and analyzed by UV/Vis to 
calculate the loop volumes.  
 
HPLC Measurement of Chlorination Products 
The concentration of products and reactants in kinetics samples were measured 
using a ThermoFinnigan (Waltham, MA) Surveyor HPLC system containing a MS Pump, 
Autosampler, and PDA detector. Standard curves were generated using pure stocks (≥ 
98% pure) of AcTyr, Ac3ClTyr, and AcCl2Tyr (r
2 ≥ 0.999). Separation of each analyte 
was accomplished by using a Restek Ultra IBD column (C18, 3µm, 150 x 2.1 mm). The 
initial solvent mix was 95% mobile phase A (0.1% aqueous TFA) and 5% mobile phase 
B (0.85% TFA in acetonitrile) for 5 minutes followed by a linear gradient to 50% B over 
20 minutes at a flow rate of 200 µL/min. The limit of detection (S/N ≥ 3) was ≈ 0.5 µM 
while the limit of quantitation was 100 - 200 M depending on the analyte. Kinetics 
samples were diluted as necessary to achieve a final concentration of analyte less than the 
limit of quantitation. The Qual browser module of Xcalibur, ver. 1.3 (Thermo-Finnigan, 
Ontario, Canada) was used to analyze the HPLC chromatogram. Standard curves were 
obtained periodically to ensure that measured concentrations were accurate.  
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Analysis of Kinetics Data and Determination of Rate Constants 
Microsoft Excel was used to analyze all kinetics data using a model comparison 
method.52 A time interval of 0.1 seconds was used to numerically model the differential 
equations. The chemical models for chlorination of phenol analogues by HOCl are 
presented in the Results section. The sum of the squared differences (SSD) was 
calculated between the experimental and modeled concentrations for time points in a 
kinetics experiment. The Solver tool in Excel was used to determine the optimized 
second order rate constants that minimized the SSD giving SSDopt. The error in each rate 
constant was estimated by determining the two rate constants that gave SSD = 
SSDopt*(F(P/(N-P))+1) where F is the critical value of the F distribution, P is the number 
of model parameters, and N is the number of data points.52 We chose a value of F 
corresponding to the 95% confidence level. When multiple rate constants were used to 
model the kinetics, the error in each rate constant was estimated while all other rate 
constants were held at their optimized value. The rate constant values are reported as the 
middle value ± ½*range; the middle value was calculated from the high and low SSD 
values calculated above that defined the range of certainty (95% confidence level) and 
were within 1% of the optimized value in most cases. 
 
Dependence of Kinetics on Presence of Chloride and Solution pH 
The reaction pH was varied from pH 4.0 to pH 10.5 and the kinetics of 
chlorination were determined when 200 µM HOCl reacted with 690 µM AcTyr or 680 
µM Ac3ClTyr at 37 °C. HOCl was prepared in phosphate buffer with or without chloride 
(Cl-) so that the final concentration of Cl- during reaction was 140 mM. The reactions 
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were stopped with a 10-fold excess of methionine after 1, 5, 10, 15, and 30 seconds using 
the KinTek Quench flow system. The apparent rate constant was modeled as described in 
the previous paragraph. The pH dependence of chlorination for tyrosine analogues was fit 
to the equation kapparent = kw[phenol][HOCl] + kx([phenol][OCl
-] + [phenolate][HOCl]) + 
ky[phenolate][OCl
-] + kz[H
+][HOCl][Cl-] where the concentrations of the acid and 
conjugate base of the tyrosine analogue or HOCl were determined by their pKa values. 
The terms [phenol][OCl-] and [phenolate][HOCl] were combined because the optimized 
rate constant for each term, when separated, was dependent on the value of the other 
term. The concentration of chlorine (Cl2) formed at equilibrium is small relative to 
HOCl/OCl- at the examined pH values indicating that any effect of chloride ion on the 
chlorination kinetics was due to either the rate limiting reaction of Cl2 formation or the 
rate of Cl2 reacting with tyrosine analogues.
53 As the effect of chloride on chlorination 
kinetics was observed to be a function of the rate of Cl2 formation, we included the effect 
of chloride using the previously determined rate law.53 
 
Chlorination of Tyrosine by HOCl in a Lysine-Containing Peptide  
The concentration of the peptide, Ac-KGNYAE-NH2, was determined using 
UV/Vis spectrometry and the molar absorptivity of tyrosine at 274 nm (ε274 nm = 1368 M-
1cm-1). Reactions contained 125 µM peptide and 65 – 400 µM of HOCl and were 
quenched with at least 10-fold excess methionine. Likewise, a mixture of the N-α-acetyl 
analogues of lysine, glycine, asparagine, tyrosine, alanine, and glutamic acid, where each 
amino acid was present at a concentration of 125 µM, was reacted with 65 – 400 µM 
HOCl. Reactants were combined manually for reaction times between 15 seconds and 60 
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minutes in an aluminum block maintained at 37 °C. The reactant and products were 
quantitated by UV-detected HPLC. The peptide reaction products were identified by 
isolating HPLC chromatographic peaks and by using MALDI-TOF mass spectrometry as 
described in Appendix A.  
Quantitation of Ac-KGNYAE-NH2 and its chloro- and dichlorotyrosine analogues 
were based on the standard curve of the AcTyr analogues. While the retention times were 
different, quantitation by this method closely matched initial quantitation by UV/Vis and 
the sum of the peptide analogues remained constant throughout the reaction. Our 
experience with Tyr and AcTyr indicated that differences in retention time, and thus 
acetonitrile content of the solvent during elution from the column, did not result in 
significant (p  0.05) changes in the calibration slope. Furthermore, our HPLC 
quantitation method was compared with a previously established GC-MS method to 
quantitating Tyr, 3ClTyr, and Cl2Tyr and showed no significant difference in 
concentration (Appendix B). The apparent rate constant of tyrosine chlorination in the 
peptide Ac-KGNYAE-NH2 or the equivalent mixture of N-acetyl amino acids was 
determined as described above.  
 
Results 
HOCl Reacts with 3ClTyr to form Cl2Tyr 
The reported loss of 3ClTyr in the presence of HOCl suggested caution when 
using 3ClTyr as a biomarker for active MPO and HOCl in vivo.1 While the previous 
reports showed that HOCl reacts with 3ClTyr to form Cl2Tyr,
42, 44-46, 48 the kinetics of this 
reaction and thus the likelihood that formation of Cl2Tyr is physiologically relevant are 
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unknown. The changes in the UV spectrum when Ac3ClTyr is reacted with HOCl are 
shown in Figure 2a. The product formed when HOCl reacts with Ac3ClTyr has 
absorbance peaks at 247 and 305 nm, consistent with the UV spectrum of synthetic 
AcCl2Tyr. However, the kinetics of tyrosine chlorination by HOCl reported by Pattison 
and Davies attributed these absorbance peak to an intermediate compound following the 
reaction of HOCl with the phenol ring of tyrosine and preceding the formation of 3ClTyr. 
We therefore reexamined the kinetics of Tyr chlorination by HOCl to determine if 
AcCl2Tyr was formed during the published experiments.
31 Figures 2b and 2c show the 
changes in the UV spectrum when AcTyr reacts with HOCl, matching the previously 
described reaction conditions and results. The kinetics of UV spectra changes indicates 
that HOCl reacts faster with Ac3ClTyr than with AcTyr. As Cl2Tyr was apparently 
formed during the published kinetics experiments, the reported rate constant of tyrosine 
chlorination may be in error.  
The UV spectrum of authentic AcTyr, Ac3ClTyr, and AcCl2Tyr is shown in 
Figure 3 at acidic, basic, and neutral pH values. The pH-dependence of the UV spectra 
for AcTyr, Ac3ClTyr, and AcCl2Tyr was used to determine the phenol pKa values of 9.8, 
8.5, and 6.7, respectively (Appendix C). The final purity of all compounds was ≥ 98% as 
determined by analytical HPLC at the maximum absorbance circa 280 nm. These spectra 
indicate the formation of both Ac3ClTyr and AcCl2Tyr when AcTyr reacts with HOCl 
(Figure 2). As the UV spectra of these compounds overlap at pH 7.4, we instead used an 
HPLC method to quantitate the formation of reaction products. The HPLC chromatogram 
shown in Figure 4 confirms that both Ac3ClTyr and AcCl2Tyr are formed after 30 
seconds when HOCl reacts with AcTyr under the same conditions as those reported while  
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A. 350 µM Ac3ClTyr + 200 µM HOCl 
 
B. 70 µM AcTyr + 200 µM HOCl 
 
  C. 350 µM AcTyr + 200 µM HOCl 
 
Figure 2: UV Spectroscopy of AcTyr or Ac3ClTyr Reacting with HOCl. HOCl reacts 
with Ac3ClTyr more rapidly than with AcTyr. The initial spectrum is shown as a bold line 
while the arrows show the changes in the spectra collected every subsequent 22 seconds. 
All reactions were performed at room temperature (approximately 22 ºC) with 200 M 
HOCl and (A) 350 M Ac3ClTyr, (B) 70 M AcTyr, or (C) 350 M AcTyr. The product 
of the reaction of Ac3ClTyr with HOCl has peaks at 246 and 305 nm (panel A). These 
peaks are also seen when HOCl reacts with small amounts of AcTyr (panel B) or with 
excess AcTyr (panel C). 
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A. AcTyr 
 
B. Ac3ClTyr 
 
C. AcCl2Tyr 
 
 
Figure 3: UV Spectrum of Tyrosine Analogues at Varying pH Values. Phosphate buffer 
at 100 mM was used to buffer the compounds in acidic, basic, and physiologic pH values. 
The spectrum of (A) AcTyr and (B) Ac3ClTyr at physiological pH is similar to the 
spectrum at acidic pH while the spectrum of (C) AcCl2Tyr is most similar to the spectrum 
at basic pH. 
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Figure 4: HPLC Detection of Products Formed when AcTyr Reacts with HOCl. Both 
Ac3ClTyr and AcCl2Tyr are formed after 30 seconds when 350 µM AcTyr is reacted with 
200 µM HOCl at 37 °C, pH 7.4. The peaks at 11.9, 16.1, and 18.6 minutes display identical 
UV spectra and coelute with authentic standards of AcTyr, Ac3ClTyr, and AcCl2Tyr, 
respectively.  
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determining the published rate constants.31 The standards were important to verify the 
identity of products and generate the standard curves for quantitation as described in the 
Experimental Procedures section. 
 
HOCl Chlorinates 3ClTyr More Rapidly than Tyr 
The time course of tyrosine analogue chlorination was monitored using UV-
detected HPLC. In all cases excess AcTyr, Ac3ClTyr, or AcCl2Tyr at nominal 
concentrations of 350, 500, and 1000 M were exposed to chlorinating agent in 100 mM 
phosphate buffer, pH 7.4. The chlorinating agent HOCl was rapidly consumed by 
addition of excess methionine to stop the reaction at the desired reaction time, usually 
between 1 second and 60 minutes. The chlorinating agents examined included HOCl, the 
monochloramine of N-acetylhistidine (AcHisCl), and the mono- and dichloramines of N- 
acetyllysine. Figure 5a shows a representative kinetic experiment for the chlorination of 
AcTyr by HOCl where first Ac3ClTyr and then AcCl2Tyr are formed. 
The time-dependence of product formation was modeled using the differential 
equations shown in Figure 6 to determine the rate constants. The reaction progress was 
modeled numerically as described in the Experimental Procedures section. The rate 
constants were determined by minimizing differences between the model and 
experimental reaction progress curves. For reactions with excess AcTyr or Ac3ClTyr, the 
loss of phenol reactant was equal to the formation of chlorinated products. However, the 
loss of AcCl2Tyr following reaction with HOCl was less than the added chlorinating 
agent, presumably due to the reaction of the unknown product with chlorinating agent. 
Therefore, only the first 2 minutes, 15 minutes, or 48 hours were modeled for HOCl,  
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A. AcTyr + HOCl 
 
B. AcTyr + AcHisCl 
 
 
Figure 5: Kinetics of AcTyr Chlorination by HOCl and AcHisCl. (A) 350 M AcTyr 
or (B) 400 M AcTyr with 1000 M AcHis were reacted with 200 M HOCl at 37 ºC for 
the indicated time; the reaction was stopped with excess methionine and the products were 
quantitated by UV- detected HPLC. The solid lines in each panel represent the modeled 
reaction progress with optimized rate constants. The rate constants k1, k2, and k3 for AcTyr, 
Ac3ClTyr, and AcCl2Tyr, respectively, reacting with HOCl in panel A are 71, 238, and 32 
M-1s-1. The rate constants k1, k2, and k3 for AcTyr, Ac3ClTyr, and AcCl2Tyr, respectively, 
reacting with AcHisCl in panel B are 2.3, 7.0, and 1.7 M-1s-1. 
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Figure 6: Kinetic Scheme for Modeling the Chlorination of AcTyr. (A) AcTyr is 
converted to Ac3ClTyr that can also react with HOCl or chloramine to form AcCl2Tyr. 
AcCl2Tyr is consumed when exposed to HOCl or chloramine to form unknown products. 
(B) The differential equations describing the change in AcTyr, Ac3ClTyr, and AcCl2Tyr 
concentration used to numerically model the experimental data. 
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AcHisCl, or the lysine chloramines, respectively, to determine the rate constants for  
AcCl2Tyr chlorination. For each chlorinating agent, all kinetics experiments at a given 
temperature with at least three different concentrations of AcTyr, Ac3ClTyr, and 
AcCl2Tyr were simultaneously modeled when determining the rate constants. The rate 
constants are summarized in Table 1. 
 
Chloride Increases Tyr Chlorination at Acidic pH Values 
The effect of chloride ions on the kinetics of tyrosine analogue chlorination was 
next investigated to determine the effect of chloride on the in vivo chlorination of protein-
bound tyrosine. Approximate chloride concentrations in vivo range from 20 mM inside 
cells, 116 mM in interstitial fluid, 100 mM in plasma, and up to 160 mM in the stomach. 
In the presence of chloride, HOCl is in equilibrium with Cl2 as shown in equation 1.
53 
    Eq. 1 
The pH-dependent nature of this equilibrium prompted an investigation of the pH 
dependence of AcTyr and Ac3ClTyr chlorination by HOCl with and without chloride as 
shown in Figure 7. The effect of chloride is only significant at acidic pH values as the  
formation of Cl2 becomes favorable. In the absence of chloride, the apparent rate constant 
was decomposed to species specific terms for the reaction of the phenol or phenolate ion 
with HOCl or hypochlorite. Initial efforts indicated that the reaction of phenol with 
hypochlorite was not distinguishable from the reaction of phenolate with HOCl 
prompting combination of these two terms with a single rate constant. The modeled 
species-specific rate constants indicate that chlorination of tyrosine occurs when the -OCl 
reacts with the phenol or HOCl reacts with the phenolate as expected for an electrophilic  
HOCl Cl
-
H
+
Cl2 H2O+ + +
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Table 1. Rate Constants for Chlorination of Tyr Analogues by HOCl and 
Chloramines. This table shows the rate constants calculated for AcTyr, Ac3ClTyr, and 
AcCl2Tyr reacting with HOCl, AcHisCl, AcLysCl, and AcLysCl2. Rate constants are 
second order (M-1s-1) and were determined at pH 7.4 in 100 mM phosphate buffer. 
 
Analogue 
Temp 
(ºC) 
HOCl AcHisCl AcLysCl AcLysCl2 Reference 
AcTyr 22 47 ± 14 9 ± 2 - - 31, 48 
 22 23 ± 2 2.0 ± 0.1 0.002 ± 0.001 0.002 ± 0.002 This Study 
 37 71 ± 8 3.0 ± 0.3 0.004 ± 0.003 0.003 ± 0.002 This Study 
Ac3ClTyr 22 82 ± 7 6.6 ± 0.4 0.003 ± 0.001 0.009 ± 0.005 This Study 
 37 238 ± 27 10.4 ± 1.0 0.008 ± 0.002 0.012 ± 0.007 This Study 
AcCl2Tyr 22 26 ± 3 1.2 ± 0.1 0.002 ± 0.002 0.004 ± 0.004 This Study 
 37 32 ± 6 1.7 ± 0.2 0.003 ± 0.002 0.006 ± 0.006 This Study 
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Figure 7: Effect of Chloride and pH on Rate of Tyrosine Chlorination. Chloride causes 
an increase in the apparent rate constant for the chlorination of tyrosine analogues by HOCl 
at a low pH. (A) AcTyr and (B) Ac3ClTyr were reacted with HOCl with (red curve) and 
without (blue curve) the presence of 140 mM chloride and modeled as described in the 
Experimental Procedures section. The solid curves represent the optimized model while 
the dashed lines represent the 95% confidence limits; overlap of these limits for the 
presence and absence of chloride is shaded grey. The presence of chloride only causes a 
significant increase in the apparent rate constant at acidic pH values. The AcTyr rate 
constants without chloride, kw, kx, and ky, are 5.3, 142, 1.3M
-1s-1, respectively. With 
chloride, the AcTyr rate constants, kw, kx, ky, and kz, are, 25, 141, 0 M
-1s-1, and 14026 M-
2s-1, respectively. The Ac3ClTyr rate constants without chloride, kw, kx, ky, are 4.8, 353, 27 
M-1s-1. With chloride present, the Ac3ClTyr rate constants, kw, kx, ky, and kz, become 72, 
363, 15 M-1s-1, and 3930 M-2s-1, respectively. 
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aromatic substitution reaction. As the equilibrium concentration of Cl2 prior to reaction 
initiation is small relative to the quantity of chlorination product observed, the influence of 
chloride was modeled by adding a term for the rate of Cl2 formation. The modeled value 
of this chloride-dependent rate constant is similar to the reported rate constant of Cl2 
formation indicating that Cl2 formation, not phenol chlorination by Cl2, is the rate-limiting 
step in tyrosine chlorination at acidic pH values.53 
 
Chloramines Chlorinate 3ClTyr More Rapidly than Tyr 
Recent reports indicate that chlorination of protein-bound tyrosine is preferred 
when a His or Lys residue is nearby, suggesting that the formation of 3ClTyr in vivo is 
accelerated by first forming a histidine or lysine chloramine.43, 44, 47 The 
monochloramines of AcHis and AcLys as well as the dichloramine of AcLys were 
reacted with the tyrosine analogues AcTyr, Ac3ClTyr, and AcCl2Tyr. At the 
concentrations used in this study, HOCl will rapidly react to form AcHisCl, AcLysCl, or 
AcLysCl2 within one second. Figure 5b shows the chlorination of AcTyr by AcHisCl 
where first Ac3ClTyr and then AcCl2Tyr are formed. All chlorinating agents also caused 
AcCl2Tyr to disappear forming one or more unknown products. As this article focuses on 
the use of 3ClTyr as a biomarker, the identity of these unknown products were not 
pursued. The relative rate of chlorination in all cases by chlorinating agents was HOCl > 
AcHisCl >> AcLysCl ≈ AcLysCl2. The kinetics of these reactions were determined as 
described in the Experimental Procedures section above and were analogous to the 
chlorination of tyrosine analogues by HOCl. 
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Analysis of AcLysCl2 kinetics is complicated due to the interaction between the 
three species of lysine. When AcLysCl2 chlorinates a tyrosine analogue, it becomes 
AcLysCl that in turn can chlorinate a tyrosine analogue. Additionally, when AcLysCl 
chlorinates AcTyr, it becomes AcLys, which can be rapidly chlorinated by AcLysCl2 to 
become AcLysCl again.54 The complete data set of AcLysCl and AcLysCl2 reactions 
were thus simultaneously modeled to determine separate rate constants for the mono- and 
dichloramine of lysine. The complete progress curve for AcTyr or Ac3ClTyr was 
modeled; only the first 15 minutes, 48 hours, or 48 hours of the progress curves of 
AcCl2Tyr reacting with AcHisCl, AcLysCl, or AcLysCl2, respectively, were modeled due 
to the apparent reaction of HOCl or chloramine with the unknown products. The rate 
constants for AcHisCl are approximately 10- to 30-fold slower than those for HOCl and 
the lysine chloramine rates are more than 10,000-fold slower (Table 1). 
 
Lysine Chloramine Rapidly Chlorinates Tyrosine in the Context of a Peptide 
 The slow chlorination of AcTyr by lysine chloramines conflicts with the selective, 
and more rapid, chlorination of tyrosine residues near a lysine residue in a peptide or 
protein.43, 44 The effect of a nearby lysine residue on the kinetics of tyrosine chlorination 
was examined in the context of the peptide Ac-KGNYAE-NH2. A mixture of N--acetyl 
analogues corresponding to the amino acid content of this peptide was also reacted with 
HOCl to serve as a control. Figure 8a shows the HPLC of 125 µM Ac-KGNYAE-NH2 
after it has reacted with 0, 130, or 260 µM HOCl for 60 minutes at 37 °C. Each peak was 
collected and analyzed by MALDI-TOF in positive- and negative-ion mode. The three 
largest HPLC peaks had mass spectra peaks of 722.3, 756.2, and 790.2 m/z that  
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Figure 8: Rapid Chlorination of Tyrosine by Lysine Chloramine in a Peptide. 
Tyrosine in a peptide is more rapidly chlorinated by a nearby lysine chloramine than by 
free AcLysCl. (A) HPLC of 125 µM Ac-KGNYAE-NH2 after a 60 minute reaction with 
either 0, 130, or 260 µM HOCl. The peaks at 8.3, 12.6, and 14.0 minutes correspond to Ac-
KGNXAE-NH2 with tyrosine, 3-chlorotyrosine, or 3,5-dichlorotyrosine, respectively, at 
residue four. The peaks at 13.6, 15.6, and 16.8 minutes correspond to the lysine nitrile form 
of the peptide with tyrosine, 3-chlorotyrosine, or 3,5-dichlorotyrosine, respectively. (B) 
125 µM Ac-KGNYAE-NH2 was reacted with 130 µM HOCl, stopped with excess 
methionine at the indicated time and then quantitated by UV-detected HPLC. The apparent 
rate constant k1 was found to be 2.4 M
-1s-1. (C) 125 µM Ac-KGNYAE-NH2 or 130 µM of 
an equivalent N-acetyl amino acid mixture was reacted with 130 µM HOCl. Chlorination 
incorporation was measured as Clincorporation = [3ClTyr] + 2 x [Cl2Tyr]. The chlorination of 
tyrosine by a free lysine chloramine is much slower than by a lysine chloramine within the 
same peptide.  
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correspond to the M+H fragment of the peptide containing Tyr, 3ClTyr, and Cl2Tyr, 
respectively. In negative ion mode, the MALDI showed three other peaks at 716.3, 750.3, 
and 784.3 m/z that correspond to the loss of four hydrogen atoms on each of these three 
analogues when the amine of lysine is oxidized to form a nitrile (Appendix B). HPLC 
was used to monitor the reaction of the peptide and HOCl over an hour (Figure 8b) and a 
rate constant k1 of 2.4 M
-1s-1 was determined by modeling as described above. 
Comparison of the chlorination kinetics for the tyrosine-containing peptide and amino 
acid mixture highlights the acceleration of tyrosine chlorination by a nearby chloramine 
(Figure 8c). 
 
Discussion 
The biomarker 3ClTyr is formed when HOCl chlorinates tyrosine. Active MPO, 
secreted by leukocytes in the innate immune response or chronic inflammation, 
synthesizes HOCl from a chloride ion and hydrogen peroxide. However, the reported loss 
of 3ClTyr to form an unknown product in the presence of HOCl calls into question the 
use of 3ClTyr as a biomarker of HOCl or active MPO.1 Previous studies indicate that 
Cl2Tyr is formed when tyrosine-containing proteins are exposed to HOCl suggesting that 
HOCl chlorinates 3ClTyr to form Cl2Tyr. This report is the first to determine the kinetics 
of HOCl reacting with the side-chains of 3ClTyr and Cl2Tyr.
42, 43, 45 
Given the overlapping UV spectra of these compounds, an HPLC-UV approach 
was chosen to monitoring the reaction kinetics. The examined compounds and 
chlorination products were cleanly separated and easily quantitated. The standard curve 
for all compounds examined gave excellent correlation coefficients, r2 ≥ 0.999; the 
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standard error for measuring the concentrations of tyrosine analogues given these 
standard curves was 8 – 12%.  
The kinetic rate constants reported in Table 1 are 2- to 4-fold slower than those 
previously reported.31, 48 We argue that this discrepancy is not due to the difference 
between the UV spectroscopy and UV-HPLC methods. The changes to the UV spectrum 
as HOCl reacts with AcTyr (Figure 2) are consistent with previous published 
descriptions. However, the UV specta (Figure 3) of authentic AcTyr, Ac3ClTyr, and 
AcCl2Tyr suggests, and the HPLC data confirms (Figure 4), that both Ac3ClTyr and 
AcCl2Tyr are formed under the reported reaction conditions.
31 The HPLC data (Figure 5) 
clearly shows that Ac3ClTyr formation precedes appearance of AcCl2Tyr. However, 
Pattison and Davies assigned the UV spectral peaks at 240 and 300 nm to an intermediate 
compound between AcTyr and AcCl2Tyr while the results reported here indicate that 
these spectral peaks are best assigned to AcCl2Tyr. The chemical model (Figure 6) used 
to derive the rate constants (Table 1) reported here differs from that of Pattison and 
Davies.31 We have no reason to question the other rate constants reported by Pattison and 
Davies as the current criticism is limited to their proposed reaction scheme for AcTyr.31, 
48 Nonetheless, the 2- to 4-fold slower rate constants of tyrosine chlorination are reported 
here, despite their minor physiological importance relative to the competing reactions of 
HOCl in vivo. 
Despite the relatively slow reaction between HOCl and protein-bound tyrosine, 
the observation of greater quantities of 3-chlorotyrosine in diseased tissues than normal 
tissues indicates that HOCl production in vivo is sufficient to chlorinate tyrosine residues 
in cellular proteins. Measurements in vivo observe 0 – 1000 mol 3ClTyr per mole 
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tyrosine in various tissues and diseases.39, 55-61 The chlorination of specific proteins, such 
as apolipoprotein A2 from atherosclerotic plaques reaches levels of 7000 mol 3ClTyr 
per mol tyrosine.41  
Consideration of the known rate constants from in vitro experiments offers some 
insights into the meaning of in vivo 3ClTyr measurements. At the physiological 
3ClTyr/Tyr ratio reported in the literature, the rate constants reported here predict only 
1% of 3ClTyr would be chlorinated to form Cl2Tyr assuming no other biologically 
relevant reactions are present. The competing reactions of HOCl with the sulfur 
containing amino acids cysteine and methionine in proteins and glutathione are rapid with 
rate constants faster than 1 x 108 M-1s-1.31, 62 Therefore, the presence of 3ClTyr observed 
in vivo is usually interpreted to represent the lower limit of HOCl formation after the 
available anti-oxidant glutathione is consumed.31, 62 The direct chlorination of 3ClTyr to 
form Cl2Tyr in vivo, given the rate constants reported here, is unlikely at 3ClTyr/Tyr 
ratios observed in vivo. 
The reaction of HOCl with amines to form a chloramine, however, has emerged 
from in vitro studies as the most likely pathway to form protein-bound 3ClTyr.43, 44 
Tyrosine residues in peptides and proteins near the N-terminal amine group or on lysine 
and histidine residues are preferentially chlorinated indicating that the formation of an 
intermediate chloramine accelerates tyrosine chlorination.43, 44, 47 Because the in vivo 
HOCl concentrations and quantities are not known, the physiological relevance of HOCl 
used during in vitro experiments is uncertain, particularly as these in vitro reactions also 
exclude glutathione. However, the quantity of Cl2Tyr formed is informative when 3ClTyr 
formation, as a ratio to Tyr, is similar to that observed in vivo. Instead of Cl2Tyr values 
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less than 1% as predicted above, in vitro experiments with histone proteins or BSA found 
approximately 10% Cl2Tyr when 3ClTyr values were less than 7,000 mol/mol of 
tyrosine, the current upper limit of 3ClTyr reported from in vivo samples.41-43 
Furthermore, for histone H3 and BSA the quantity of HOCl needed to produce these 
physiological quantities of 3ClTyr was less than the number of cysteine and/or 
methionine residues indicating that either the kinetics of HOCl reduction by these 
residues is less than expected, presumably due to burial by the protein structure, or that 
acceleration of tyrosine chlorination by first forming nearby chloramines is sufficiently 
fast to successfully compete with cysteine and methionine residues.  
Chlorination of a peptide-bound tyrosine by a nearby lysine chloramine may be 
further favored because of this chloramines decreased reactivity with glutathione (Figure 
9). Lysine chloramine reacts more slowly with glutathione (~300 M-1s-1) than HOCl or 
histidine chloramine, allowing lysine chloramine to persist longer in solution and 
facilitate chlorination of nearby tyrosine residues.31, 62 Additionally, while lysine 
chloramine can eventually undergo hydrolysis into an aldehyde or nitrile,65 chlorination 
of a nearby tyrosine appears to be a more favorable reaction based on the absence of 
lysine modifications and prevalence of 3ClTyr in previous studies.42, 43  
The primary limitation of the chloramine rate constants reported in Table 1 is that 
they are bimolecular and represent the restriction of more degrees of freedom during 
chlorination of tyrosine than would occur when a chloramine chlorinates a nearby 
tyrosine residue on the same polypeptide chain. Inclusion of a nearby lysine residue on 
the same peptide chain accelerated the rate of tyrosine chlorination by approximately 
600-fold (Figure 8) and nearby histidine residues also appear to favor tyrosine  
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Figure 9: Summary of Reactions by HOCl that Compete with 3ClTyr Formation. All 
rate constants are for individual amino acid analogues. The rate constants for HOCl or 
chloramines reacting with sulfur containing amino acids or glutathione and primary amines 
reacting with HOCl are published elsewhere.31, 34 The remaining rate constants are from 
Table 1. 
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chlorination.43, 48, 66, 67 The maximal rate enhancement is likely higher than that observed 
here when a less flexible polypeptide backbone and an optimal position of the chloramine 
relative to the phenol ring are present, warranting further investigation.  
The kinetics of AcTyr or Ac3ClTyr by HOCl is pH dependent (Figure 7) and 
phenolate is more rapidly chlorinated by HOCl as expected for an electrophilic aromatic 
substitution reaction. The phenolate form is approximately 25- to 400-fold more rapidly 
chlorinated than the phenol form of AcTyr; the uncertainty in this rate enhancement is 
because the data did not allow us to discriminate between hypochlorous acid reacting 
with the phenolate and the phenol reacting with hypochlorite. A possible explanation of 
the effect of neighboring histidine or lysine residues on the kinetics of tyrosine 
chlorination is that these basic residues lower the pKa value of tyrosine, accelerating the 
reaction kinetics. However, the apparent rate enhancement of tyrosine in the context of a 
peptide can be over 500-fold, suggesting that this alternate explanation is not the major 
reason for selective chlorination of tyrosine residues near lysine or histidine. 
Furthermore, the pKa value of the phenol group in the peptide was no different than that 
of AcTyr, eliminating this possible mechanism of enhanced kinetics in our model.  
The equilibrium between HOCl and Cl2, another chlorinating agent present at 
acidic pH values in the presence of chloride ions, could influence the in vivo kinetics of 
tyrosine chlorination. While chloride had no significant effect on tyrosine chlorination at 
the neutral pH values (Figure 7) found in blood and most human tissue, a significant 
increase in tyrosine chlorination kinetics is expected in the stomach given its acidic pH 
and high chloride concentration, as observed in the stomach of rats.68 Modeling the effect 
of chloride concentration on tyrosine chlorination indicated that the rate enhancement 
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was approximately equal to the published rate of Cl2 formation.
53 The actual rate of 
tyrosine chlorination by Cl2 was not accessible by the experiments described here, but is 
expected to be approximately 100-fold faster given its kinetics with phenol.69 
Most reports that measure 3ClTyr from in vivo tissues did not also measure 
Cl2Tyr. However, other reports that measured both 3ClTyr and Cl2Tyr observed 
quantities of Cl2Tyr approaching the quantity of 3ClTyr observed.
61, 64, 70 The nasal tissue 
of Fisher 344 rats exposed to chlorine gas resulted in equal quantities of 3ClTyr and 
Cl2Tyr;
70 this result could be due to the different mechanism, relative to HOCl, of 
tyrosine chlorination by Cl2.
69 Of more relevance to the in vivo kinetics of HOCl is the 
observation of Cl2Tyr in both bacterial and neutrophil proteins where up to one third of 
chlorinated tyrosine residues were Cl2Tyr.
64 The observation of 3ClTyr in the sputum of 
asthmatic subjects was not significantly different than that of normal controls, however, 
Cl2Tyr was significantly elevated.
61 The chemical reaction and rate constants reported 
here indicate that the formation of 3ClTyr is limited by the formation of Cl2Tyr with 
exposure to significant quantities of HOCl. In control tissues with activated neutrophils, 
Cl2Tyr formation may be a better biomarker of disease processes.  
The above predictions based on rate constants reported here indicate that 
formation of the free amino acid Cl2Tyr is not likely. However, the limited reports 
measuring protein-bound Cl2Tyr in biological tissue further suggest that the formation of 
protein-bound Cl2Tyr is more likely and could prove important in unraveling questions 
concerning physiological relevant levels of HOCl synthesis.  
  
 48 
References 
1. Whiteman, M., and Spencer, J. P. (2008) Loss of 3-chlorotyrosine by inflammatory 
oxidants: implications for the use of 3-chlorotyrosine as a bio-marker in vivo. 
Biochem Biophys Res Commun, 371, 50-53. 
2. Pickup, J. C. (2004) Inflammation and activated innate immunity in the pathogenesis 
of type 2 diabetes. Diabetes Care, 27, 813-823. 
3. Heneka, M. T., and O'Banion, M. K. (2007) Inflammatory processes in Alzheimer's 
disease. Journal of Neuroimmunology, 184, 69-91. 
4. Moisse, K., and Strong, M. J. (2006) Innate immunity in amyotrophic lateral 
sclerosis. Biochimica Et Biophysica Acta-Molecular Basis of Disease, 1762, 1083-
1093. 
5. Nijhuis, M. M. O., van Keulen, J. K., Pasterkamp, G., Quax, P. H., and de Kleijn, D. 
P. V. (2007) Activation of the innate immune system in atherosclerotic disease. 
Current Pharmaceutical Design, 13, 983-994. 
6. Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer. Nature, 420, 860-
867. 
7. Roncucci, L., Mora, E., Mariani, F., Bursi, S., Pezzi, A., Rossi, G., Pedroni, M., 
Luppi, D., Santoro, L., Monni, S., Manenti, A., Bertani, A., Merighi, A., Benatti, P., 
Di Gregorio, C., and de Leon, M. P. (2008) Myeloperoxidase-positive cell infiltration 
in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidem 
Biomar, 17, 2291-2297. 
8. Babior, B. M. (2000) Phagocytes and oxidative stress. Am J Med, 109, 33-44. 
9. Klebanoff, S. J. (2005) Myeloperoxidase: friend and foe. J Leukocyte Biol, 77, 598-
625. 
10. Pullar, J. M., Vissers, M. C., and Winterbourn, C. C. (2000) Living with a killer: the 
effects of hypochlorous acid on mammalian cells. IUBMB Life, 50, 259-266. 
11. Weiss, S. J. (1989) Tissue destruction by neutrophils. N Engl J Med, 320, 365-376. 
12. Martinez-Cayuela, M. (1995) Oxygen free radicals and human disease. Biochimie, 
77, 147-161. 
13. Dalle-Donne, I., Scaloni, A., Giustarini, D., Cavarra, E., Tell, G., Lungarella, G., 
Colombo, R., Rossi, R., and Milzani, A. (2005) Proteins as biomarkers of 
oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass 
Spectrom Rev, 24, 55-99. 
 49 
14. Daugherty, A., Dunn, J. L., Rateri, D. L., and Heinecke, J. W. (1994) 
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human 
atherosclerotic lesions. J Clin Invest, 94, 437-444. 
15. Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., and Libby, 
P. (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage 
colony-stimulating factor in human atherosclerosis and implications in acute coronary 
syndromes. American Journal of Pathology, 158, 879-891. 
16. Rainis, T., Maor, I., Lanir, A., Shnizer, S., and Lavy, A. (2007) Enhanced oxidative 
stress and leucocyte activation in neoplastic tissues of the colon. Digest Dis Sci, 52, 
526-530. 
17. Choi, D. K., Pennathur, S., Perier, C., Tieu, K., Teismann, P., Wu, D. C., Jackson-
Lewis, V., Vila, M., Vonsattel, J. P., Heinecke, J. W., and Przedborski, S. (2005) 
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of 
Parkinson's disease in mice. Journal of Neuroscience, 25, 6594-6600. 
18. Green, P. S., Mendez, A. J., Jacob, J. S., Crowley, J. R., Growdon, W., Hyman, B. T., 
and Heinecke, J. W. (2004) Neuronal expression of myeloperoxidase is increased in 
Alzheimer's disease. Journal of Neurochemistry, 90, 724-733. 
19. Nagra, R. M., Becher, B., Tourtellotte, W. W., Antel, J. P., Gold, D., Paladino, T., 
Smith, R. A., Nelson, J. R., and Reynolds, W. F. (1997) Immunohistochemical and 
genetic evidence of myeloperoxidase involvement in multiple sclerosis. Journal of 
Neuroimmunology, 78, 97-107. 
20. King, C. C., Jefferson, M. M., and Thomas, E. L. (1997) Secretion and inactivation of 
myeloperoxidase by isolated neutrophils. J Leukocyte Biol, 61, 293-302. 
21. Bradley, P. P., Christensen, R. D., and Rothstein, G. (1982) Cellular and Extracellular 
Myeloperoxidase in Pyogenic Inflammation. Blood, 60, 618-622. 
22. Edwards, S. W., Hughes, V., Barlow, J., and Bucknall, R. (1988) Immunological 
Detection of Myeloperoxidase in Synovial-Fluid from Patients with Rheumatoid-
Arthritis. Biochemical Journal, 250, 81-85. 
23. Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., and Milzani, A. (2006) 
Biomarkers of oxidative damage in human disease. Clin Chem, 52, 601-623. 
24. Atkinson, A. J., Colburn, W. A., DeGruttola, V. G., DeMets, D. L., Downing, G. J., 
Hoth, D. F., Oates, J. A., Peck, C. C., Schooley, R. T., Spilker, B. A., Woodcock, J., 
Zeger, S. L., and Grp, B. D. W. (2001) Biomarkers and surrogate endpoints: Preferred 
definitions and conceptual framework. Clinical Pharmacology & Therapeutics, 69, 
89-95. 
 50 
25. Winterbourn, C. C., and Kettle, A. J. (2000) Biomarkers of myeloperoxidase-derived 
hypochlorous acid. Free Radic Biol Med, 29, 403-409. 
26. Whiteman, M., Jenner, A., and Halliwell, B. (1997) Hypochlorous acid-induced base 
modifications in isolated calf thymus DNA. Chem Res Toxicol, 10, 1240-1246. 
27. Badouard, C., Masuda, M., Nishino, H., Cadet, J., Favier, A., and Ravanat, J. L. 
(2005) Detection of chlorinated DNA and RNA nucleosides by HPLC coupled to 
tandem mass spectrometry as potential biomarkers of inflammation. J Chromatogr B 
Analyt Technol Biomed Life Sci, 827, 26-31. 
28. Kreutzer, D. A., and Essigmann, J. M. (1998) Oxidized, deaminated cytosines are a 
source of C -> T transitions in vivo. P Natl Acad Sci USA, 95, 3578-3582. 
29. Theruvathu, J. A., Kim, C. H., Rogstad, D. K., Neidigh, J. W., and Sowers, L. C. 
(2009) Base Pairing Configuration and Stability of an Oligonucleotide Duplex 
Containing a 5-Chlorouracil-Adenine Base Pair. Biochemistry, 48, 7539-7546. 
30. Valinluck, V., Liu, P., Kang, J. I., Jr., Burdzy, A., and Sowers, L. C. (2005) 5-
halogenated pyrimidine lesions within a CpG sequence context mimic 5-
methylcytosine by enhancing the binding of the methyl-CpG-binding domain of 
methyl-CpG-binding protein 2 (MeCP2). Nucleic Acids Res, 33, 3057-3064. 
31. Pattison, D. I., and Davies, M. J. (2001) Absolute rate constants for the reaction of 
hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol, 14, 
1453-1464. 
32. Pattison, D. I., Hawkins, C. L., and Davies, M. J. (2003) Hypochlorous acid-mediated 
oxidation of lipid components and antioxidants present in low-density lipoproteins: 
absolute rate constants, product analysis, and computational modeling. Chem Res 
Toxicol, 16, 439-449. 
33. Hawkins, C. L., Pattison, D. I., and Davies, M. J. (2002) Reaction of protein 
chloramines with DNA and nucleosides: evidence for the formation of radicals, 
protein-DNA cross-links and DNA fragmentation. Biochem J, 365, 605-615. 
34. Prutz, W. A. (1996) Hypochlorous acid interactions with thiols, nucleotides, DNA, 
and other biological substrates. Arch Biochem Biophys, 332, 110-120. 
35. Hawkins, C. L., Pattison, D. I., and Davies, M. J. (2003) Hypochlorite-induced 
oxidation of amino acids, peptides and proteins. Amino Acids, 25, 259-274. 
36. Malle, E., Hazell, L., Stocker, R., Sattler, W., Esterbauer, H., and Waeg, G. (1995) 
Immunological Detection and Measurement of Hypochlorite-Modified Ldl with 
Specific Monoclonal-Antibodies. Arterioscl Throm Vas, 15, 982-989. 
 51 
37. Malle, E., Waeg, G., Schreiber, R., Grone, E. F., Sattler, W. S., and Grone, H. J. 
(2000) Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system 
in human atherosclerotic lesions - Colocalization of myeloperoxidase and 
hypochlorite-modified proteins. European Journal of Biochemistry, 267, 4495-4503. 
38. Hazen, S. L., Crowley, J. R., Mueller, D. M., and Heinecke, J. W. (1997) Mass 
spectrometric quantification of 3-chlorotyrosine in human tissues with attomole 
sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed 
chlorination at sites of inflammation. Free Radic Biol Med, 23, 909-916. 
39. Buss, I. H., Senthilmohan, R., Darlow, B. A., Mogridge, N., Kettle, A. J., and 
Winterbourn, C. C. (2003) 3-Chlorotyrosine as a marker of protein damage by 
myeloperoxidase in tracheal aspirates from preterm infants: association with adverse 
respiratory outcome. Pediatr Res, 53, 455-462. 
40. Cheng, M. L., Chen, C. M., Gu, P. W., Ho, H. Y., and Chiu, D. T. (2008) Elevated 
levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese 
patients with acute myocardial infarction. Clin Biochem, 41, 554-560. 
41. Zheng, L., Nukuna, B., Brennan, M. L., Sun, M., Goormastic, M., Settle, M., Schmitt, 
D., Fu, X., Thomson, L., Fox, P. L., Ischiropoulos, H., Smith, J. D., Kinter, M., and 
Hazen, S. L. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-
catalyzed oxidation and functional impairment in subjects with cardiovascular 
disease. J Clin Invest, 114, 529-541. 
42. Chapman, A. L., Senthilmohan, R., Winterbourn, C. C., and Kettle, A. J. (2000) 
Comparison of mono- and dichlorinated tyrosines with carbonyls for detection of 
hypochlorous acid modified proteins. Arch Biochem Biophys, 377, 95-100. 
43. Kang, J. I., Jr., and Neidigh, J. W. (2008) Hypochlorous acid damages histone 
proteins forming 3-chlorotyrosine and 3,5-dichlorotyrosine. Chem Res Toxicol, 21, 
1028-1038. 
44. Bergt, C., Fu, X., Huq, N. P., Kao, J., and Heinecke, J. W. (2004) Lysine residues 
direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when 
hypochlorous acid oxidizes high density lipoprotein. J Biol Chem, 279, 7856-7866. 
45. Fu, S., Wang, H., Davies, M., and Dean, R. (2000) Reactions of hypochlorous acid 
with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products 
in addition to 3-chlorotyrosine. J Biol Chem, 275, 10851-10858. 
46. Drabik, G., and Naskalski, J. W. (2001) Chlorination of N-acetyltyrosine with HOCl, 
chloramines, and myeloperoxidase-hydrogen peroxide-chloride system. Acta 
Biochimica Polonica, 48, 271-275. 
 52 
47. Domigan, N. M., Charlton, T. S., Duncan, M. W., Winterbourn, C. C., and Kettle, A. 
J. (1995) Chlorination of tyrosyl residues in peptides by myeloperoxidase and human 
neutrophils. J Biol Chem, 270, 16542-16548. 
48. Pattison, D. I., and Davies, M. J. (2005) Kinetic analysis of the role of histidine 
chloramines in hypochlorous acid mediated protein oxidation. Biochemistry, 44, 
7378-7387. 
49. Hunt, S. (1984) Halogenated tyrosine derivatives in invertebrate scleroproteins: 
isolation and identification. Methods Enzymol, 107, 413-438. 
50. Allevi, P., Olivero, P., and Anastasia, M. (2004) Controlled synthesis of labelled 3-L-
chlorotyrosine-[ring-C-13(6)] and of 3,5-L-dichlorotyrosine-[ring-C-13(6)]. J 
Labelled Compd Rad, 47, 935-945. 
51. Morris, J. C. (1966) Acid Ionization Constant of HOCl from 5 to 35 Degrees. Journal 
of Physical Chemistry, 70, 3798-&. 
52. Motulsky, H., and Christopoulos, A. (2005) Fitting Models to Biological Data Using 
Linear and Nonlinear Regression,   pp 109 - 117, GraphPad Software, San Diego, 
CA. 
53. Wang, T. X., and Margerum, D. W. (1994) Kinetics of Reversible Chlorine 
Hydrolysis - Temperature-Dependence and General Acid Base-Assisted Mechanisms. 
Inorganic Chemistry, 33, 1050-1055. 
54. Pattison, D. I., and Davies, M. J. (2006) Evidence for rapid inter- and intramolecular 
chlorine transfer reactions of histamine and carnosine chloramines: implications for 
the prevention of hypochlorous-acid-mediated damage. Biochemistry, 45, 8152-8162. 
55. Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., 
Anantharamaiah, G. M., Chait, A., Brunzell, J., Geary, R. L., Oram, J. F., and 
Heinecke, J. W. (2004) The myeloperoxidase product hypochlorous acid oxidizes 
HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. 
Proc Natl Acad Sci U S A, 101, 13032-13037. 
56. Citardi, M. J., Song, W., Batra, P. S., Lanza, D. C., and Hazen, S. L. (2006) 
Characterization of oxidative pathways in chronic rhinosinusitis and sinonasal 
polyposis. Am J Rhinol, 20, 353-359. 
57. Hazen, S. L., and Heinecke, J. W. (1997) 3-Chlorotyrosine, a specific marker of 
myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein 
isolated from human atherosclerotic intima. J Clin Invest, 99, 2075-2081. 
58. Himmelfarb, J., McMenamin, M. E., Loseto, G., and Heinecke, J. W. (2001) 
Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free 
Radic Biol Med, 31, 1163-1169. 
 53 
59. Mita, H., Higashi, N., Taniguchi, M., Higashi, A., Kawagishi, Y., and Akiyama, K. 
(2004) Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic 
patients: lack of increase in 3-bromotyrosine concentration in urine and plasma 
proteins in aspirin-induced asthma after intravenous aspirin challenge. Clin Exp 
Allergy, 34, 931-938. 
60. Shao, B. H., Oda, M. N., Oram, J. F., and Heinecke, J. W. (2010) Myeloperoxidase: 
An Oxidative Pathway for Generating Dysfunctional High-Density Lipoprotein. 
Chemical Research in Toxicology, 23, 447-454. 
61. Aldridge, R. E., Chan, T., Van Dalen, C. J., Senthilmohan, R., Winn, M., Venge, P., 
Town, G. I., and Kettle, A. J. (2002) Eosinophil peroxidase produces hypobromous 
acid in the airways of stable asthmatics. Free Radical Bio Med, 33, 847-856. 
62. Peskin, A. V., and Winterbourn, C. C. (2001) Kinetics of the reactions of 
hypochlorous [7]acid and amino acid chloramines with thiols, methionine, and 
ascorbate. Free Radic Biol Med, 30, 572-579. 
63. Pastore, A., Federici, G., Bertini, E., and Piemonte, F. (2003) Analysis of glutathione: 
implication in redox and detoxification. Clinica Chimica Acta, 333, 19-39. 
64. Chapman, A. L., Hampton, M. B., Senthilmohan, R., Winterbourn, C. C., and Kettle, 
A. J. (2002) Chlorination of bacterial and neutrophil proteins during phagocytosis and 
killing of Staphylococcus aureus. J Biol Chem, 277, 9757-9762. 
65. Joo, S. H., and Mitch, W. A. (2007) Nitrile, aldehyde, and halonitroalkane formation 
during chlorination/chloramination of primary amines. Environ Sci Technol, 41, 
1288-1296. 
66. Nightingale, Z. D., Lancha, A. H., Jr., Handelman, S. K., Dolnikowski, G. G., Busse, 
S. C., Dratz, E. A., Blumberg, J. B., and Handelman, G. J. (2000) Relative reactivity 
of lysine and other peptide-bound amino acids to oxidation by hypochlorite. Free 
Radic Biol Med, 29, 425-433. 
67. Pattison, D. I., Hawkins, C. L., and Davies, M. J. (2007) Hypochlorous acid-mediated 
protein oxidation: How important are chloramine transfer reactions and protein 
tertiary Structure? Biochemistry, 46, 9853-9864. 
68. Nickelsen, M. G., Nweke, A., Scully, F. E., Ringhand, H. P. (1992) Reactions of 
aqueous chlorine in vitro in stomach fluid from the rat: chlorination of tyrosine. Chem 
Res Toxicol, 4, 94-101. 
69. Grimley, E., and Gordon, G. (1973) Kinetics and Mechanism of Reaction between 
Chlorine and Phenol in Acidic Aqueous-Solution. Journal of Physical Chemistry, 77, 
973-978. 
 54 
70. Sochaski, M. A., Jarabek, A. M., Murphy, J., and Andersen, M. E. (2008) 3-
chlorotyrosine and 3,5-dichlorotyrosine as biomarkers of respiratory tract exposure to 
chlorine gas. J Anal Toxicol, 32, 99-105.  
 55 
CHAPTER THREE 
KINETICS OF 3-NITROTYROSINE CHLORINATION BY HYPOCHLOROUS 
ACID AND CHLORAMINES 
 
 Matthew P. Curtis, Jonathan W. Neidigh 
 
Department of Basic Sciences, Loma Linda University School of Medicine 
Loma Linda, CA 92350 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Curtis, M.P., and Neidigh, J.W. (2014). Free Radical Res. 48: p. 1355-
1362.  
 56 
Abstract 
The markers 3-nitrotyrosine and 3-chlorotyrosine are measured as surrogates for 
reactive nitrogen species and hypochlorous acid, respectively, which are both elevated in 
inflamed tissues of humans. However, a previous study1 observed that 3-nitrotyrosine is 
lost when exposed to hypochlorous acid suggesting that 3-nitrotyrosine underestimates 
the reactive nitrogen species present in diseased tissues when 3-chlorotyrosine is also 
present. This study evaluates the significance of this qualitative finding by measuring the 
kinetics of 3-nitrotyrosine loss upon reaction with hypochlorous acid. The results 
demonstrate that 3-nitrotyrosine is chlorinated by hypochlorous acid or chloramines to 
form 3-chloro-5-nitrotyrosine. As 3-nitrotyrosine from in vivo samples is usually found 
within proteins, as opposed to the free amino acid, we also examined the reaction of 3-
nitrotyrosine loss in the context of peptides. The chlorination of 3-nitrotyrosine in 
peptides was observed to occur up to 700 fold faster than control reactions using 
equivalent amino acid mixtures and depended on the peptide sequence. The chlorination 
in peptides whereby the rapid intermolecular formation of a peptide chloramine is 
followed by a slower intramolecular chlorination of 3-nitrotyrosine is supported by the 
observed first order kinetics of chlorination during the rate limiting intramolecular 
reaction. These results further advance our understanding of the chloramine-dependence 
of tyrosine chlorination in peptides improving the ability to predict likely damage sites in 
proteins. 
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Introduction 
Reactive chemicals are implicated in the pathology of human diseases associated 
with aberrant or chronic inflammation including cancer, neurodegenerative diseases, and 
cardiovascular disease.2-5 The innate immune cells recruited to inflamed tissues by 
cytokines express enzymes that catalyze the synthesis of these reactive chemicals.6-11 
Myeloperoxidase catalyzes the oxidation of chloride ions by hydrogen peroxide to form 
hypochlorous acid (HOCl) that damages biological molecules including tyrosine free in 
solution and tyrosine residues in proteins to form 3-chlorotyrosine (3ClTyr).12, 13 Reactive 
nitrogen species, such as peroxynitrite and nitrogen dioxide formed when nitric oxide is 
oxidized, damage biological molecules such as free or protein-bound tyrosine to produce 
3-nitrotyrosine (NO2Tyr).
5 The markers NO2Tyr and 3ClTyr are measured as surrogates, 
respectively, of reactive nitrogen species and HOCl formed in vivo because these tyrosine 
damage products are chemically stable and readily measured with existing analytical 
methods.14-17 One study, however, demonstrated in vitro that NO2Tyr is lost in the 
presence of HOCl suggesting that the observed NO2Tyr underestimates the levels of 
reactive nitrogen species in tissues that also produce HOCl.1  
The coincident formation of reactive halogen and reactive nitrogen species occurs 
when the enzymes myeloperoxidase and nitric oxide synthase are both present. 
Myeloperoxidase can consume nitric oxide in the presence of hydrogen peroxide and 
generate reactive nitrogen species capable of nitrating tyrosine residues to form 
NO2Tyr.
18, 19 Resting human neutrophils isolated from peripheral blood do not normally 
express inducible nitric oxide synthase (iNOS).7 However, activated neutrophils exposed 
to cytokines can express iNOS, produce nitric oxide, and increase the level of reactive 
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nitrogen species suggesting that recruitment of neutrophils during inflammation can 
increase both tyrosine nitration and chlorination. Some populations of tissue 
macrophages, notably those found in atherosclerotic plaques and the brain, contain both 
iNOS and myeloperoxidase.7 The observation of both 3ClTyr and NO2Tyr in diseased 
tissues of patients with atherosclerosis, cardiovascular disease, or neurodegeneration 
confirms the presence of active MPO in tissues with reactive nitrogen species.11, 20, 21  
The kinetics of NO2Tyr reacting with HOCl or HOCl-derived chloramines is 
important for estimating the loss of the marker NO2Tyr in vivo when both reactive 
nitrogen species and active myeloperoxidase are present. The kinetics reported here 
include the direct reaction of HOCl or chloramines with NO2Tyr and the reaction of 
HOCl to form a peptide-bound chloramine followed by indirect chlorination of a nearby 
NO2Tyr residue. The product of NO2Tyr chlorination, 3-chloro-5-nitrotyrosine 
(ClNO2Tyr), is also reported. Comparison of the intramolecular and intermolecular 
chlorination kinetics of NO2Tyr by chloramines indicates that the indirect chlorination of 
tyrosine residues is accelerated relative to the otherwise slow intermolecular rates for free 
amino acids. The relevance of these results to the chlorination of tyrosine residues to 
form the biomarker 3ClTyr is discussed. 
 
Experimental Procedures 
Materials 
N-Acetyl-L-tyrosine (AcTyr), N-α-acetyl-L-lysine (AcLys), and N-acetyl-L-
histidine (AcHis) were purchased from Novabiochem (San Diego, CA). FMOC-amide 
resin was purchased from Applied Biosystems, Inc. (Foster City, CA). FMOC-OSu, 
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FMOC-Lys(BOC)-OH, FMOC-His(Trt)-OH, and all other FMOC amino acids were 
purchased from Advanced ChemTech (Louisville, KY), with the exception of FMOC-
Tyr(NO2)-OH which was synthesized as described below. All other laboratory chemicals 
were purchased from Sigma-Aldrich (St. Louis, MO). 
 
Synthesis of N-acetyl-3-nitrotyrosine 
3-Nitro-L-tyrosine was acetylated with excess acetic anhydride in acetone at room 
temperature (Figure 1). After reacting overnight, the product, N-acetyl-3-nitrotyrosine 
(AcNO2Tyr), was formed and found soluble in acetone. The acetone was evaporated by 
use of a rotary evaporator and any remaining acetic anhydride was hydrolyzed by the 
addition of water. The solution was added to a SupelClean, LC-18 packing, solid phase 
extraction (SPE) column (Supelco, Bellefonte, PA). The column was washed with 0.1% 
trifluoroacetic acid (TFA) and subsequent washes were composed of increasing 
concentrations of methanol (5% increments) in 0.1% TFA. Aliquots were analyzed by 
analytic HPLC to determine the purity and fractions > 98% pure were combined and 
lyophilized. The compound gave the expected UV/vis maximums at 279 nm and 360 
nm.22 The 1H-NMR spectra is consistent with AcNO2Tyr. 
1H-NMR (500 MHz, DMSO): 
12.72 (s, 1H, -CO2H ), 10.79 (s, 1H, -OH), 8.18 (d, J = 8.1 Hz, 1H, NH), 7.74 (d, J = 2.0 
Hz, 1H, H2), 7.41 (dd, J = 2.0, 8.5 Hz, 1H, H6), 7.05 (d, J = 8.5 Hz, 1H, H5), 4.38 (m, 
1H, Hα), 3.01 (dd, J = 4.7, 13.9 Hz, 1H, Hβ), 2.80 (dd, J = 9.4, 13.9 Hz, Hβ), 1.78 (s, 3H, 
CH3). 
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A. Synthesis of Ac3ClTyr 
 
B. Synthesis of AcCl2Tyr 
 
Figure 1: Synthesis of AcNO2Tyr and AcClNO2Tyr. AcNO2ClTyr was synthesized by 
acetylation of NO2Tyr with excess acetic anhydride (Ac2O) (A). AcClNO2Tyr was 
synthesized by acetylation of 3ClTyr with subsequent nitration by excess sodium nitrate in 
sulfuric acid (B). 
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Synthesis of N-acetyl-3-chloro-5-nitrotyrosine 
3-Chloro-L-tyrosine (3ClTyr) was acetylated as described previously. The crude 
product, N,O-diacetyl-3-chlorotyrosine, was produced after an overnight reaction and is 
soluble in acetone. The acetone was evaporated and the crude compound was then 
dissolved in water. Excess sodium nitrate (approximately 3-fold) was added, the solution 
was placed on ice, and then concentrated sulfuric acid was added dropwise to hydrolyze 
the phenol acetate ester and nitrate the phenol giving N-acetyl-3-chloro-5-nitrotyrosine 
(AcClNO2Tyr) (Figure 1). The solution was allowed to react for two hours before being 
purified by SPE as described above. Analytical HPLC showed the final purity was > 
98%. The UV/vis spectrum shows maximums at 285 nm and 358 nm under acidic 
conditions. The 1H-NMR is consistent with AcClNO2Tyr. 
1H-NMR (500 MHz, DMSO): 
12.77 (s, 1H, -CO2H), 10.91 (s, 1H, -OH), 8.21 (d, J=8.3 Hz, 1H, NH), 7.79 (d, J = 2.0 
Hz, 1H, H6), 7.70 (d, J = 2.0 Hz, 1H, H2), 4.43 (m, 1H, Hα), 3.05 (dd, J = 4.8, 13.8 Hz, 
1H, Hβ), 2.83 (dd, J = 9.7, 13.8 Hz, 1H, Hβ), 1.80 (s, 3H, CH3). 
 
Synthesis of N-FMOC-3-nitrotyrosine 
An FMOC protecting group was added to the N-terminus of NO2Tyr by reacting 
with equimolar FMOC-OSu and 3-fold excess sodium bicarbonate in a 50:50 mixture of 
water and acetone. After stirring overnight at room temperature, the aqueous layer was 
extracted four times with diethyl ether. The combined diethyl ether solution was back-
extracted twice with a 5% sodium bicarbonate solution. The combined aqueous layers 
were acidified by adding concentrated HCl until precipitate formed. The product was 
extracted with ethyl acetate twice, combined, and dried using anhydrous magnesium 
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sulfate. Finally, the solvent was removed by rotary evaporation, leaving a golden powder 
for use in peptide synthesis. 
 
Peptide Synthesis and Purification 
Peptides containing histidine or lysine residues in close proximity to the NO2Tyr 
residue were synthesized on an ABI model 433A peptide synthesizer using fast FMOC 
chemistry. Following synthesis, the N-terminus was acetylated using acetic anhydride. 
The protecting groups and resin support were cleaved from the peptides using a mixture 
of TFA/phenol/water/triisopropylsilane (88:5:5:2). The resin was removed by filtration, 
the cleavage reaction was concentrated by rotary evaporation, and then the peptide was 
precipitated by adding cold diethyl ether to the cleavage mixture. The ether was removed 
following centrifugation to pellet the precipitated peptide. After washing the crude 
peptide with cold diethyl ether three times, the peptides were purified by reverse phase 
HPLC using a C18 column (Varian Dynamax, 250 mm x 21.4 mm, 300 Å, 5 µM) with a 
gradient of 20 - 60% mobile phase B (acetonitrile with 0.085% TFA) where mobile phase 
A contained aqueous 0.1% TFA. The sequence of the purified peptides was confirmed by 
MS/MS using a ThermoFinnigan LCQ Deca XP mass spectrometer, and a purity of > 
95% was verified by analytical HPLC. 
 
Methods 
The purchased sodium hypochlorite stock was stored at 4 °C. The pKa of HOCl is 
7.5 resulting in almost equal concentrations of hypochlorous acid and its conjugate base, 
hypochlorite, at physiological pH. The term “hypochlorous acid” is thus used to refer to 
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both the acid and its conjugate base. The concentration of the sodium hypochlorite stock 
was determined daily using the absorbance at 290 nm (ε290 nm = 350 M-1cm-1) for a fresh 
dilution of the stock into 0.1 M NaOH.23 Dilutions of HOCl stock were then made into 20 
- 200 mM phosphate buffer. The stock concentrations of NO2Tyr or AcClNO2Tyr 
containing chemicals were determined following dilution into 0.1 M HCl and using 
UV/vis spectroscopy with molar absorptivity values of ε360 nm= 2790 M-1cm-1 and ε358 nm= 
2496 M-1cm-1, respectively. The molar absorptivity value of ClNO2Tyr was determined 
as a ratio of the published value for NO2Tyr by mixing AcClNO2Tyr and AcNO2Tyr 
stock solutions with known UV spectra, vacuum centrifuging to remove water, dissolving 
in deuterated DMSO, collecting a 1D NMR spectrum, and calculating the ratio of both 
compounds based on pairs of integrated peaks corresponding to the same resonance.22  
 
Reactions of AcNO2Tyr with HOCl or Chloramines 
All reactions contained 200 μM HOCl, 400 – 1000 μM AcNO2Tyr, and 100 mM 
phosphate buffer at the indicated pH. For reactions with lysine or histidine chloramines, 
five-fold excess AcLys or AcHis was added to the AcNO2Tyr solution before the 
addition of HOCl. Previous studies pre-formed the chloramine by addition of HOCl to 
AcHis,23 but when comparing techniques, there was no significant difference in 
ClNO2Tyr product formation. Reactants were mixed in 1.5 mL glass vials in an 
aluminum block maintained at 37 °C with stir bars in the reaction vessels. All reactions 
with HOCl or chloramines were quenched with 10-fold excess methionine or cysteine, 
respectively, at time points ranging between 5 seconds and 2 hr. 
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UV/Vis Spectroscopy of AcClNO2Tyr Chlorination by HOCl 
The UV-spectra of AcClNO2Tyr reacting with HOCl was measured on a Varian 
(Palo Alto, CA) Cary 100 Bio UV/vis spectrophotometer in a 1-cm micro quartz cell. 
AcClNO2Tyr (185 µM) was reacted with 720 µM HOCl at 37 ºC and the spectra between 
350 and 550 nm were measured every 24 seconds. 
 
Reaction of Peptides with HOCl 
HOCl was reacted with excess peptide at 20 – 240 µM peptide and 10 - 120 µM 
HOCl in 10 mM phosphate buffer at the indicated pH. Reactants were rapidly mixed in a 
1.5 mL glass vials in an aluminum block at 37 ºC and quenched with 10-fold excess of 
cysteine at time points between 5 seconds and 12 hr. 
 
HPLC Quantitation of Reaction Products 
The concentration of products and reactants in kinetic samples were measured 
using a ThermoFinnigan (Waltham, MA) Surveyor HPLC system with a MS Pump, 
Autosampler, and PDA detector (200-600 nm). Standard curves were generated using 
stocks (> 98% pure) of AcNO2Tyr and AcClNO2Tyr (r
2 > 0.999). Separation of each 
analyte was accomplished using a Restek Ultra IBD column (C18, 3 μm, 150 x 2.1 mm). 
The initial solvent mix was 95% mobile phase A (0.1% TFA in water) and 5% mobile 
phase B (0.085% TFA in acetonitrile) for 5 min followed by a linear gradient to 50% 
mobile phase B over 20 min at a flow rate of 100 μL/min. The gradient stayed constant 
for 2.5 min followed by a linear decrease to 5% B in 2.5 min. The limit of detection (S/N 
> 3) was ≈ 0.1 μM while the limit of quantitation was approximately 120 μM for each 
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analyte. Kinetics samples were diluted as necessary to achieve a final concentration of 
AcNO2Tyr and AcClNO2Tyr less than the limit of quantitation. AcNO2Tyr and 
AcClNO2Tyr were quantitated at 360 nm. The Qual browser module of Xcalibur, ver. 1.3 
(Thermo-Finnigan, Ontario, Canada) was used to analyze the HPLC chromatogram. 
Standard curves using AcNO2Tyr and AcClNO2Tyr were obtained regularly to ensure 
accuracy of measured concentrations. 
 
Determination of Initial Reaction Rate and Reaction Order 
The lysine-containing peptides were reacted with HOCl and quenched with excess 
cysteine at 37 °C in 10 mM phosphate buffer at pH 7.4. Four or five time points were 
chosen in which the product formation was less than 20% of the initial HOCl 
concentration. The reported initial reaction rate of NO2Tyr chlorination, V0, was 
determined as the slope of product formation with respect to time that is by a linear line. 
The V0 of 12-15 reactions with various initial concentrations of peptide and HOCl were 
used to solve for the reaction order using the equation V0 = k * [Peptide]0
A * 
[Chloramine]0
B, where A and B are the rate order of peptide and chloramine, 
respectively. Because HOCl reacts with lysine forming a chloramine significantly faster 
than any measurable formation of ClNO2Tyr, the initial concentration of chloramine 
peptide is equivalent to the initial concentration of HOCl.25  
 
Analysis of Kinetics Data and Determination of Rate Constants 
Microsoft Excel was used to analyze all kinetic data using a model comparison 
method.26 A time interval of 0.1 seconds was used to numerically model the differential 
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equations. The chemical models for chlorination of NO2Tyr by HOCl or chloramines are 
presented in the Results section. The sum of the squared differences (SSD) was 
calculated between the experimental and modeled concentrations for time points in a 
kinetics experiment. The Solver tool in Excel was used to determine the optimized 
second order rate constants that minimized the SSD giving SSDopt. The error in each rate 
constant was estimated by determining the rate constant that gave SSD = 
SSDopt*(F(P/(N-P))+1) where F is the critical value of the F distribution, P is the number 
of model parameters, and N is the number of data points. We chose a value of F 
corresponding to the 95% confidence level. The rate constant values are reported as 
middle value ± ½*range; the middle value was calculated from the high and low SSD 
values that defined the range of certainty (95% confidence level) and were within 1% of 
the optimized value in all cases. 
 
Results 
HOCl Reacts with NO2Tyr to Form ClNO2Tyr 
The published chlorination of 3-substituted tyrosine analogues by HOCl 
suggested that the loss of 3-nitrotyrosine observed previously resulted in the formation of 
3-chloro-5-nitrotyrosine.1, 27 To avoid the competing reaction of HOCl with the amino 
group of 3-nitrotyrosine, the acetylated analogues of NO2Tyr and ClNO2Tyr were 
synthesized.28 The 1H-NMR and UV/vis spectra were consistent with the expected 
structure and HPLC indicated that the purified compounds were > 98% pure.  The pKa 
values of AcNO2Tyr and AcClNO2Tyr were determined by UV/vis spectroscopy to be 
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7.1 ± 1 and 5.4 ± 1, respectively (Appendix D). The pKa of AcNO2Tyr is comparable to 
the previously published pKa value of NO2Tyr (7.2-7.5).
29  
The reaction of AcNO2Tyr with HOCl to form AcClNO2Tyr was monitored by 
HPLC. All reactions were initiated by adding HOCl in concentrated buffer (200 mM, pH 
of 7.4) to equal volumes of the AcNO2Tyr in purified water with and without excess 
AcHis or AcLys present. The reactions were stopped by adding a minimum 10-fold 
excess methionine or cysteine which rapidly reacts with any remaining HOCl or 
chloramine, respectively.24, 25, 30 Figure 2 shows the formation of AcClNO2Tyr after a 
30-second reaction of AcNO2Tyr with HOCl. The observed product peak had the same 
retention time and UV spectra as observed for the authentic standard of AcClNO2Tyr. 
We monitored the reactions between AcNO2Tyr and HOCl, N-acetylhistidine 
chloramine (AcHisCl), or N-α-acetyllysine chloramine (AcLysCl) at pH 7.4 and 37 °C 
between 5 seconds and 120 min. AcNO2Tyr at concentrations of approximately 500, 750, 
and 1000 μM were reacted with 200 μM HOCl both in the presence and absence of 
excess AcHis or AcLys. The reaction of 750 µM AcNO2Tyr with 200 µM HOCl (Figure 
3a) or AcHisCl (Figure 3b) results in AcClNO2Tyr production. The reaction with 
AcLysCl was too slow to produce any measureable amount of AcClNO2Tyr after two 
hours but product was seen the next day (data not shown). In all cases, the total amount 
of AcClNO2Tyr produced was less than the initial amount of HOCl, suggesting that 
HOCl further reacts with AcClNO2Tyr to form compounds without UV absorbance at 
wavelengths longer than 200 nm.27 Due to this apparent reaction, only the early time 
points where the AcClNO2Tyr concentration was less than 30% of the initial HOCl 
concentration were modeled to calculate the rate constants. One possible explanation as  
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Figure 2: Separation and Quantitation of AcNO2Tyr and AcClNO2Tyr by HPLC. 
AcClNO2Tyr is formed after 500 μM AcNO2Tyr is reacted with 200 μM HOCl at 37 °C, 
pH 7.4. The reaction was stopped by the addition of excess methionine after 30 s. The 
peaks at 22.8 and 25.7 min have identical UV spectra and retention times as authentic 
standards of AcNO2Tyr and AcClNO2Tyr, respectively.  
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A. AcNO2Tyr + HOCl 
 
B. AcNO2Tyr + AcHisCl 
 
 
Figure 3: Kinetics of AcNO2Tyr Chlorination by HOCl or AcHisCl. (A) 780 µM 
AcNO2Tyr or (B) 730 µM AcNO2Tyr with 1000 µM AcHis were reacted with 200 µM 
HOCl at 37 °C for the indicated time; the reaction was stopped with excess methionine, 
and the products were quantitated by UV-detected HPLC. The solid lines in each panel 
represent the modeled reaction progress with optimized rate constants. The rate constant k1 
for AcNO2Tyr reacting with HOCl in panel A is 24.5 M
-1s-1. The rate constant k1 for 
AcNO2Tyr reacting with AcHisCl in panel B is 1.0 M
-1s-1. Similar experiments were done 
for AcLysCl but no product was measured after two hours of reaction. 
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to the loss of chlorinating potential is the degradation and loss of AcHisCl as previously 
reported.30 However, even tripling the reported rate of AcHisCl degradation and 
incorporating that into our model, we saw no significant change in our rate constant or the 
available amount of AcHisCl during the earlier time points. The complete set of data for 
AcNO2Tyr reacting with HOCl or AcHisCl was modeled to obtain a single set of rate 
constants, summarized in Table 1. 
 
HOCl Reacts with AcClNO2Tyr to Form Unknown Products 
We investigated the reaction of AcClNO2Tyr with HOCl by HPLC and UV/vis. 
No product peaks were identified by UV-HPLC and the measured loss of AcClNO2Tyr 
was less than the initial HOCl introduced. This would seem to indicate that an unknown 
product with no significant UV/vis chromophore forms and that it reacts more readily 
with HOCl than AcClNO2Tyr. We followed the loss of AcClNO2Tyr in the presence of 
HOCl by UV/vis at 37 °C, pH 7.4 (Figure 4). The rate of loss of AcClNO2Tyr decreases 
as the reaction progresses, indicative of the unknown products being able to successfully 
compete with AcClNO2Tyr for reaction with HOCl. It takes approximately 6-fold excess 
HOCl to completely degrade AcClNO2Tyr (data not shown). Possible products could be 
chlorinated ketones and chloroform, as seen when phenol analogues are reacted with 
excess HOCl,31 but as the focus of this report is the physiological significance of NO2Tyr 
loss, we did not identify the unknown products or reaction kinetics when ClNO2Tyr 
reacts with HOCl. 
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Table 1: Rate Constants for Chlorination of Tyrosine, 3ClTyr, and NO2Tyr.a 
Chlorinating 
Species 
AcTyrb 
(M-1s-1) 
Ac3ClTyrb 
(M-1s-1) 
AcNO2Tyr 
(M-1s-1) 
HOCl 71 ± 8 238 ± 27 24.5 ± 1.2 
HisCl 3.0 ± 0.3 10.4 ± 1.0 1.1 ± 0.2 
LysCl 0.004 ± 0.003 0.008 ± 0.002 NDc 
 
aReactions were performed at 37 ºC, pH 7.4 in 100 mM phosphate buffer. 
bRate constants were reported previously in reference 27. 
cNo significant amount of product was detected after two hours of reaction. 
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 A. UV/vis Spectrum of AcClNO2Tyr + HOCl 
 
  
 B. Consumption of AcClNO2Tyr by HOCl  
 
 
Figure 4: UV/Vis Analysis of AcClNO2Tyr Reacting with HOCl. (A) UV spectrum of 
185 μM AcClNO2Tyr reacting with 720 μM HOCl at 37 °C, pH 7.4. The initial spectrum 
is shown as a bold line while the arrow shows the changes in the spectra collected every 
subsequent 24 s. (B) The consumption of 185 μM AcClNO2Tyr by 720 μM HOCl at 37 
°C, pH 7.4. The concentration of AcClNO2Tyr was based on the absorbance at 430 nm and 
a molar absorptivity value of ε430 = 4205 M-1cm-1. The change in the rate of AcClNO2Tyr 
degradation indicates multiple reactions going on, likely between HOCl and the product of 
AcClNO2Tyr chlorination. It takes approximately six-fold excess HOCl to completely 
degrade AcClNO2Tyr (data not shown). 
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Rate of NO2Tyr Chlorination by HOCl Increases in Peptides 
Previous studies indicate that chlorination of tyrosine residues in polypeptides is 
facilitated by nearby histidine or lysine residues.24, 27, 32 We reacted the synthetic peptide, 
Ac-HGNY(NO2)AE-NH2, with a 0.5-fold concentration of HOCl and followed product 
formation by HPLC as shown in Figure 5. An amino acid mixture of N-acetyl amino 
acids that match the residue composition of the peptide Ac-HGNY(NO2)AE-NH2 was 
also reacted with 0.5-fold concentration of HOCl as a control reaction (Figure 5). The 
reactions were quenched with excess cysteine at various time points and the peptide 
reactants and products were quantitated by HPLC.   The production of ClNO2Tyr in the 
peptide was approximately 700-fold faster than in the amino acid mixture at the 
concentrations and reaction conditions examined.  
 
NO2Tyr Chlorination by HOCl in Peptides is a First Order Reaction 
To probe the mechanism whereby neighboring lysine or histidine residues facilitate 
NO2Tyr chlorination, we varied the peptide and HOCl concentrations to determine the 
order of the reaction kinetics. The initial reaction kinetics were measured to minimize the 
effect of ClNO2Tyr reacting with HOCl or chloramines. Initial experiments found that the 
reaction kinetics were independent of the initial peptide concentration and changed only 
with the amount of HOCl. The reaction kinetics shown in Figure 6 indicate that the 
kinetics are first order with respect to chloramine-containing peptide concentration which 
is equivalent to the amount of HOCl. Given the rapid reaction of HOCl with a peptide 
amine that is complete within 1 second, the reaction is first order with respect to 
chloramine concentration provided the peptide is present in excess. The rate constants of  
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Figure 5: Acceleration of NO2Tyr Chlorination by His Chloramine in a Peptide. 75 
µM Ac-HGNY(NO2)AE-NH2 or an analogous amino acid mixture were reacted with 37.5 
µM HOCl at 37 °C for the indicated times; the reaction was stopped with excess cysteine 
and the products were quantitated by UV-detected HPLC. At the concentrations indicated 
here, the rate of NO2Tyr chlorination in the peptide is approximately 700-fold faster than 
in the analogues amino acid mixture. 
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 A. Intramolecular – First Order  
 
 
  
 B. Intramolecular - Second Order 
 
 
Figure 6: Determining the Rate Order of NO2Tyr Chlorination by Chloramines 
within a Peptide. Excess Ac-KGNY(NO2)AE-NH2 was reacted with HOCl at 37 ºC, pH 
7.4. The initial reaction rate was determined by using HPLC to measure the formation of 
ClNO2Tyr at early time points where less than 20% of the reactant peptide was consumed. 
Samples were quenched with excess cysteine before HPLC. The initial reaction rate was 
calculated by linearly fitting the early time points. Because the reaction of Lys with HOCl 
is significantly faster than the chlorination of NO2Tyr, it was assumed that the 
concentration of peptide containing lysine chloramine was equal to the amount of HOCl 
added. The initial reaction rate was plotted to (A) the concentration of Ac-
K(Cl)GNY(NO2)AE-NH2 to model a first-order reaction and to (B) the square of the 
concentration of this peptide to model a second-order reaction. The linearity of the first-
order fit indicates that NO2Tyr is chlorinated through an intramolecular reaction with the 
lysine chloramine. 
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NO2Tyr chlorination by chloramine intermediates in the peptides we synthesized in this 
study are summarized in Table 2. 
 
Discussion 
Reactive nitrogen species (RNS) chemically damage tyrosine residues to form 3-
nitrotyrosine (NO2Tyr), a surrogate marker used to investigate the role of RNS in human 
diseases. However, Whiteman and Halliwell reported that NO2Tyr disappears when 
exposed to HOCl suggesting that observed NO2Tyr underestimates the role of RNS in 
tissues when chlorinating species are also present.1 That study did not report the resulting 
product when NO2Tyr reacts with HOCl, but subsequent studies on the reaction of HOCl 
with 3ClTyr to form Cl2Tyr suggested that the expected product should be ClNO2Tyr.
27, 
33-35 This expectation is now confirmed since reaction of AcNO2Tyr with HOCl forms a 
new product that has the same HPLC retention time and UV-spectra as authentic 
AcClNO2Tyr (Figure 2).  
The extent of NO2Tyr loss depends on the quantity of HOCl produced and the 
kinetics of NO2Tyr chlorination. The kinetics of AcNO2Tyr reacting with HOCl or 
chloramines were accurately determined by HPLC (Figure 3) and are reported in Table 
1. While the kinetics of 3ClTyr reacting with HOCl or a histidine chloramine are 
approximately three times faster than tyrosine chlorination, the kinetics of NO2Tyr 
chlorination are three times slower. The 3-nitro groups on chlorination kinetics is 
consistent with an electrophilic aromatic substitution reaction where the kinetics of 
chlorination are slower due to the electron withdrawing groups deactivating the aromatic 
ring. The kinetics of chlorination is affected by pH with maximum rates at pH values of  
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Table 2: Rate Constants for Chlorination of Tyr and NO2Tyr within a Peptidea 
 
 
Peptide Sequence 
 
 
Rate Constant (s-1) 
 
 
pKa 
 
Ac-HGN-Y(NO2)-AE-NH2 2.60 ± 0.53 x 10
-2 6.9 ± 0.1 
Ac-KGN-Y(NO2)-AE-NH2 2.54 ± 0.03 x 10
-5 6.9 ± 0.1 
Ac-KGN-Y-AE-NH2 2.38 ± 0.07 x 10
-4 9.8 ± 0.1 
 
aReactions were performed at 37 ºC, pH 7.4 in 10 mM phosphate buffer. 
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7.4 and 8.0 for NO2Tyr (Appendix E) and 3ClTyr, respectively.
27 The faster kinetics of 
chlorination at these pH values is consistent with an electrophilic aromatic substitution 
reaction where a phenolate is more reactive than a phenol. 
As observed with Cl2Tyr,
27 ClNO2Tyr also reacts with HOCl to form multiple 
compounds without a UV spectrum as shown in Figure 4. The reaction of ClNO2Tyr 
with chlorinating compounds to form compounds with no UV absorption explains the 
apparent loss of tyrosine analogues observed by UV-detected HPLC at longer reaction 
times and/or higher ratios of chlorinating agent relative to tyrosine analogue. The 
reported kinetics rates used excess NO2Tyr and were calculated using earlier reaction 
times where the loss of ClNO2Tyr was not observed. 
Measurements of 3ClTyr or NO2Tyr from biological tissues usually measure these 
surrogate markers in the context of proteins instead of the free amino acid. The 
observation that tyrosine residues with a nearby histidine or lysine residues are 
preferentially chlorinated is better explained by the intramolecular reaction with a nearby 
chloramine than the direct intermolecular chlorination by HOCl to form a protein-bound 
3ClTyr.24, 27, 33, 35, 36 The fast reaction of HOCl with protein amines (~105 M-1s-1) better 
competes with the antioxidant glutathione (~108 M-1s-1) than the direct chlorination of 
tyrosine analogues (~102 M-1s-1) and explains the preferential chlorination of some 
protein-bound tyrosine residues, provided the intramolecular kinetics are sufficiently 
fast.25, 32  
The rates of tyrosine, 3ClTyr, or NO2Tyr chlorination by a histidine chloramine in 
Table 1 are 24-fold slower than the reaction with HOCl. However, the rate of NO2Tyr  
chlorination by HOCl is 700-fold faster in the peptide Ac-HGNY(NO2)AE-NH2 than an 
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equivalent amino acid mix containing AcNO2Tyr and Ac-His (Figure 5). We argue that 
this increased rate of chlorination is due to the reduced degrees of freedom and close 
proximity maintained between the histidine chloramine and the NO2Tyr residues in the 
peptide context. The rapid intermolecular reaction of HOCl with a polypeptide amine to 
form a chloramine followed by the slower intramolecular chlorination of a nearby 
tyrosine analogue predicts that the kinetics of peptide tyrosine chlorination will follow 
first order kinetics. To our knowledge, this study is the first to demonstrate that the 
kinetics of tyrosine chlorination in a peptide with nearby amine follows first order 
kinetics (Figure 6).  
The second order kinetics of AcTyr or N-acetyl-3chlorotyrosine (Ac3ClTyr) 
chlorination by lysine chloramines is approximately 1000 times slower than chlorination 
by histidine chloramines.27 Likewise, the first order kinetics of NO2Tyr chlorination in a 
peptide by a lysine chloramine is 1000 times slower than a histidine chloramine (Table 
2). Figure 7 shows the intermolecular and intramolecular reaction schemes used in this 
report to extract first and second order rate constants. It should be noted that AcHisCl 
and, to a lesser extent, AcLysCl naturally decompose,30, 37 but this rate was not 
incorporated into our model since it had no significant effect at the concentrations and 
time points used in this study. 
Given the slow intermolecular kinetics of NO2Tyr chlorination, the loss of 
NO2Tyr in proteins due to HOCl likely requires a nearby lysine or histidine residue. For 
example, Tyr192 of apolipoprotein A-1 can be nitrated or chlorinated suggesting that 
measurements of Tyr192 nitration will underestimate RNS when HOCl is present.38 
However, selective tyrosine nitration is reported to have different sequence requirements  
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A. Intermolecular Scheme 
 
 
B. Intramolecular Scheme 
 
 
 
Figure 7: Kinetics Schemes for the Chlorination of NO2Tyr by HOCl. (A) HOCl 
converts AcNO2Tyr to AcClNO2Tyr which is consumed when exposed to HOCl or 
chloramines to form unknown products. (B) When NO2Tyr is on a peptide containing a 
nearby lysine or histidine, the amine is first rapidly chlorinated by HOCl in an 
intermolecular reaction. The rate of chloramine formation by HOCl, k3, is much greater 
than the direct chlorination of NO2Tyr by HOCl, k1. The peptide chloramine then 
chlorinates NO2Tyr in an intramolecular reaction to form ClNO2Tyr. 
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than selective tyrosine chlorination suggesting that loss of NO2Tyr in the presence to 
HOCl will depend on the specific tyrosine residue examined.39-42 It should be 
acknowledged that with the low rate of NO2Tyr chlorination by HOCl, it is unlikely that 
the product, ClNO2Tyr, would be important physiologically. Of greater concern is the 
loss of 3ClTyr in the presence of HOCl, since the same sequence characteristics, a nearby 
histidine or lysine, favor tyrosine chlorination as well as 3ClTyr chlorination to Cl2Tyr. 
While most studies only measure 3ClTyr, some reports that measure 3ClTyr and Cl2Tyr 
find significant quantities of both chlorination products when the quantity of 3ClTyr is 
consistent with the quantities observed in vivo indicating that published 3ClTyr levels and 
may underestimate the extent of HOCl production.27, 34, 35, 43, 44 Future measurements of 
3ClTyr should also include Cl2Tyr in order to better estimate the extent of HOCl 
production in vivo. 
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Abstract 
The molecule 3-chlorotyrosine (3ClTyr), formed when hypochlorous acid (HOCl) 
chlorinates tyrosine, is a biomarker of inflammation. HOCl can also chlorinate histidine 
or lysine side-chains creating chloramines. It has been postulated previously that 3ClTyr 
formation in vivo is predominantly through chloramine intermediates, as evidenced by the 
increased incidence of chlorination of tyrosine residues that are nearby histidine or lysine 
residues in a protein. While previous studies have shown how yields of 3ClTyr change 
depending on the positioning of lysine with respect to tyrosine in a peptide, they have 
failed to measure the change in the rate of chlorination. In this study, we use linear 
peptide sequences containing 3-nitrotyrosine (NO2Tyr) and lysine at different positions to 
explore the effect this has on the rate of chlorination of the tyrosine analogue. We also 
synthesized and characterized a cyclic ten-residue peptide designed to structurally 
constrain tyrosine and lysine residues nearby in space to better facilitate chlorination. In 
simple linear peptides, the rate of chlorination changes based on the position of lysine to 
tyrosine such that KxY > KY > KxxY > KxxxY, where x represents a residue that is 
unreactive with HOCl. The rate of chlorination is further increased if the secondary 
structure constricts lysine and tyrosine nearby in space, as determined in the gramicidin S 
analogue cyclo-P(OH)TKLDFP(OH)TYLDF. The intramolecular rate constants of 
tyrosine chlorination for all synthesized peptides are reported and the results discussed in 
relation to previous literature.  
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Introduction 
 Hypochlorous acid (HOCl) is the primary reactive oxygen species (ROS) 
produced by activated neutrophils at sites of inflammation. Phagocytic leukocytes, 
including neutrophils, monocytes, and macrophages, all generate reactive oxygen and 
chlorine species to kill invading microorganisms or in the clearance of damaged tissue.1, 2 
In humans, the production of HOCl is unique to the activity of the enzyme 
myeloperoxidase (MPO) which utilizes hydrogen peroxide (H2O2) and chloride ions to 
generate this reactive species.3  
While the generation of HOCl is typically confined to vesicles containing 
engulfed bacteria,4, 5 reactive species produced by phagocytes can also cause damage to 
host tissues.3, 6 For example, neutrophils can actively secrete MPO into the extracellular 
environment and disruption in enzyme trafficking can result in production of superoxide 
and H2O2 outside the cell.
7-11 It is thought that the generation of reactive species in 
chronically inflamed tissue contributes to the pathogenesis of several diseases, including 
the formation of atherosclerotic plaques,12-14 neurodegenerative diseases,15-18 arthritis,19, 20 
and certain cancers.21-24 
The high reactivity of HOCl means that it only exists transiently in vivo. To 
determine the extent of HOCl production we must use more stable markers, typically the 
byproducts of HOCl reacting with the bases of DNA or the amino acids of proteins. 
While HOCl reacts with DNA bases to form hydroxylated or chlorinated uracil and 
cytosine,25-27 damaged DNA bases can be readily repaired. The reaction with the amine 
groups of histidine or lysine side-chains to form chloramines is rapid,28, 29 but these 
chloramines can react further and chlorinate other compounds.29-31 The chlorination of 
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tyrosine, however, forms stable and unique products 3-chlorotyrosine (3ClTyr) and 3,5-
dichlorotyrosine (Cl2Tyr).
32-34 These two markers have been measured from in vivo 
samples including in asthmatic sputum and in cultures in which staphylococcus aureus is 
phagocytized by neutrophils.35, 36  
The direct chlorination of tyrosine residues by HOCl or HOCl-induced 
chloramines is slow.37 This contradicts studies that show greater yields of 3ClTyr and 
Cl2Tyr at tyrosine residues that are near histidine or lysine residues within proteins, 
particularly those that are in a KxxY sequence motif, where x is a residue that is 
unreactive with HOCl.33, 38 The mechanism of 3ClTyr formation proposed by others38, 39 
and determined in our previous studies37, 40 is by the intramolecular reaction between a 
lysine or histidine chloramine and a nearby tyrosine. While the effect of the spacing 
between lysine and tyrosine residues on the yield of 3ClTyr has been explored 
previously, there have been no studies examining how this changes the rate of 
chlorination and comparing this rate to competing reactions with HOCl. 
In this study, we synthesized several peptides containing histidine or lysine with a 
varying number of residues between them and a 3-nitrotyrosine (NO2Tyr) residue. 
NO2Tyr was chosen because it has a slower rate of reaction with HOCl or chloramines 
than unmodified tyrosine yet undergoes the same mechanism of chlorination, making the 
formation of chlorinated product easier to follow.40 These peptides were reacted with 
HOCl and the rate of chlorination were measured to determine the effect the primary 
structure had on tyrosine chlorination. Additionally, a cyclic peptide with a beta-sheet 
motif was designed and synthesized to position a lysine and tyrosine residue in 
constrained positions close in space in hopes of increasing the rate of chlorination. This 
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secondary structure of this peptide was characterized by circular dichroism (CD) 
spectroscopy and the rate of chlorination by HOCl was determined. The kinetics of 
chlorination of these peptides further support the role of chloramines in the formation of 
3ClTyr and Cl2Tyr  within peptides and should allow future researchers greater ability to 
predict the likelihood of tyrosine chlorination and better determine the degree of MPO 
activity in chronically inflamed tissue. 
  
Experimental Procedures 
Materials 
N-Acetyl-L-tyrosine (AcTyr), N-α-acetyl-L-lysine (AcLys), and N-acetyl-L-
histidine (AcHis) were purchased from Novabiochem (San Diego, CA). FMOC-amide 
resin was purchased from Applied Biosystems, Inc. (Foster City, CA). FMOC-OSu, 
FMOC-Lys(Boc)-OH, FMOC-His(Trt)-OH, and all other FMOC amino acids were 
purchased from Advanced ChemTech (Louisville, KY), with the exception of FMOC-
Tyr(NO2)-OH which was synthesized as described below. All other laboratory chemicals 
including 3-chloro-L-tyrosine, 3-nitro-L-tyrosine, L-methionine, sodium hypochlorite, N-
acetylglycine, N-acetyl-L-alanine, and N-acetyl-L-glutamic acid were purchased from 
Sigma-Aldrich (St. Louis, MO). Synthesis of N-FMOC-3-nitrotyrosine was performed as 
described in Chapter 3.  
 
Linear Peptide Synthesis and Purification 
Linear peptides containing lysine residues in varying proximity to the NO2Tyr 
residue were synthesized on an ABI model 433A peptide synthesizer using fast FMOC 
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chemistry. Following synthesis, the N-terminus was acetylated using acetic anhydride. 
The protecting groups and resin support were cleaved from the peptides using a mixture 
of TFA/phenol/water/triisopropylsilane (88:5:5:2). The resin was removed by filtration, 
the cleavage reaction was concentrated by rotary evaporation, and then the peptide was 
precipitated by adding cold diethyl ether to the cleavage mixture. The ether was removed 
following centrifugation to pellet the precipitated peptide. After washing the crude 
peptide with cold diethyl ether three times, the peptides were purified by reverse phase 
HPLC using a C18 column (Varian Dynamax, 250 mm x 21.4 mm, 300 Å, 5 µM) with a 
gradient of 20 - 60% mobile phase B (acetonitrile with 0.085% TFA) where mobile phase 
A contained aqueous 0.1% TFA. The sequence of the purified peptides was confirmed by 
MS/MS using a ThermoFinnigan LCQ Deca XP mass spectrometer, and a purity of > 
95% was verified by analytical HPLC. 
 
Synthesis of DPhe-chlorotrityl Resin 
 1 g of 2-chlorotrityl chloride resin was washed in dichloromethane (DCM) and 
the resin was filtered. 2 mmol of FMOC-DPhe-OH and 5 mmol of N,N-
diisopropylethylamine (DIPEA) were dissolved in DCM and added to the resin. The resin 
was washed twice with dimethylformamide (DMF) and a mixture of 
DCM/methanol/DIPEA (80:15:5) was added to the resin for 10 min twice. The resin was 
then washed with DMF three times then suspended in 25% piperidine in DMF while 
being shaken for twenty minutes. The resin was washed again in DMF six times, 
isopropanol three times, and hexane four times. The final product was dried by suction 
and stored at 4 °C until use for peptide synthesis. 
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Cyclic Peptide Synthesis and Purification 
 The cyclic, 10-residue peptide cyclo-P(OH)TKLDFP(OH)TYLDF (Figure 1) was 
based on gramicidin S, another cyclic peptide that mimics a beta-pleated sheet motif.41 
The linear, protected peptide was synthesized on DPhe-chlorotrityl resin using 
fast FMOC chemistry and an ABI peptide synthesizer as described above. Beginning 
with a DPhe-chlorotrityl resin has been shown to result in the highest yield of the final 
cyclized product.44 The chlorotrityl resin was selectively removed while keeping the side-
chain protecting groups intact by suspending the resin in 2,2,2-trifluoroethanol and DCM 
(2:8) for 45 minutes at room temperature and filtering off the resin. The filtrate was 
concentrated by rotary evaporation and the peptide was precipitated by the addition of 
hexane and ether. The peptide was then centrifugated and the pellet was washed twice 
with ether, leaving a linear, side-chain protected peptide, NH2-
P(OH)TKLDFP(OH)TYLDF-OH. 
 Approximately 100 mg of the crude, protected, linear peptide was diluted heavily 
in 200 mL of DCM in order to favor intramolecular cyclization over intermolecular 
polymerization.44 Cyclization was initiated by the addition of HBTU, HoBt hydrate, and 
DIPEA to a final concentration of 1 mM, 1 mM, and 2 mM respectively. The reaction 
was conducted at room temperature overnight and concentrated by rotary evaporation. 
Following cyclization, the side-chain protecting groups were cleaved by reacting with 
TFA/phenol/water/triisopropylsilane (88:5:5:2) for two hours followed by washing with 
diethyl ether. The crude, cyclic peptide was purified by HPLC and the sequence was 
confirmed by MS/MS as described above. Fragmentation of the cyclic peptide by MS/MS  
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Figure 1: Structure of cyclo-P(OH)TKLDFP(OH)TYLDF. This structure was based on 
the cyclic decapeptide gramicidin S, which is a known beta-sheet analogue. DPhe-Pro 
bonds induce II’ beta-turns and hydrogen bonds between anti-parallel strands further 
stabilize the structure.42, 43 When this ten-residue peptide is cyclized, the side-chains of 
lysine (red) and tyrosine (blue) are on the same surface of the ring structure. 
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showed unique peptides confirming the cyclization occurred between the N-terminal 
hydroxyproline and C-terminal phenylalanine (Appendix F) 
 
Methods 
The purchased sodium hypochlorite stock was stored at 4 °C. The pKa of HOCl is 
7.5 resulting in almost equal concentrations of hypochlorous acid and its conjugate base, 
hypochlorite, at physiological pH. The term “hypochlorous acid” is thus used to refer to 
both the acid and its conjugate base. The concentration of the sodium hypochlorite stock 
was determined daily using the absorbance at 290 nm (ε290 nm = 350 M-1cm-1) for a fresh 
dilution of the stock into 0.1 M NaOH.45 Dilutions of HOCl stock were then made into 20 
mM phosphate buffer at pH 7.4. The stock concentrations of peptides containing Tyr or 
NO2Tyr were determined following dilution into 0.1 M HCl and using UV/vis 
spectroscopy with molar absorptivity values of ε275 nm = 1368 M-1cm-1 and ε360 nm = 2790 
M-1cm-1, respectively.46, 47 
 
Reaction of Peptides with HOCl 
200 µL of HOCl was reacted with an equal volume of excess peptide at 
concentrations of 10 - 120 µM HOCl and 20 – 240 µM peptide in 10 mM phosphate 
buffer at pH 7.4. Reactants were rapidly mixed in 1.5 mL glass vials in an aluminum 
block at 37 ºC and the reaction was stopped by the addition of 200 µL of 10-fold excess 
cysteine at time points between 5 s and 12 hr. 
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HPLC Quantitation of Reaction Products 
The concentration of products and reactants in kinetic samples were measured 
using a ThermoFinnigan (Waltham, MA) Surveyor HPLC system with a MS Pump, 
Autosampler, and PDA detector (200-600 nm). The solvent gradients used for peptides 
containing tyrosine or NO2Tyr are described in Chapters 2 and 3, respectively. Kinetic 
samples were run directly on the HPLC without further dilution. The Qual browser 
module of Xcalibur, ver. 1.3 (Thermo-Finnigan, Ontario, Canada) was used to analyze 
the HPLC chromatogram. Standard curves using N-acetylated analogues of tyrosine, 
3ClTyr, and Cl2Tyr or NO2Tyr and N-acetyl-3-chloro-5-nitrotyrosine (ClNO2Tyr) were 
obtained periodically to ensure that measured concentrations were accurate. ClNO2Tyr 
was synthesized as previously described.40 
 
Analysis of Kinetics Data and Determination of Rate Constants 
Microsoft Excel was used to analyze all kinetic data using a model comparison 
method.48 The kinetic scheme and the differential equations used to model the rate 
constant are described in Figure 2. A time interval of 0.1 s was used to numerically 
model the differential equations. The sum of the squared differences (SSD) was 
calculated between the experimental and modeled concentrations for time points in a 
kinetics experiment. The Solver tool in Excel was used to determine the optimized 
second order rate constants that minimized the SSD giving SSDopt. The error in each rate 
constant was estimated by determining the rate constant that gave SSD = 
SSDopt*(F(P/(N-P))+1) where F is the critical value of the F distribution, P is the number 
of model parameters, and N is the number of data points. We chose a value of F  
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A. Scheme of Intramolecular Tyr or NO2Tyr Chlorination 
 
B. Differential Equations 
𝑑[Chloramine/Tyr]
𝑑𝑡
= −k1 ∗ [Chloramine/Tyr Peptide] 
𝑑[Amine/3ClTyr]
𝑑𝑡
= +k1 ∗ [Chloramine/Tyr Peptide] 
Figure 2: Kinetic Scheme of Intramolecular Tyrosine Chlorination. (A) The 
chlorination of tyrosine or NO2Tyr by HOCl in a lysine-containing peptide is through a 
chloramine intermediate. Lysine’s side-chain amine is chlorinated quickly relative to the 
rate of tyrosine chlorination, such that any HOCl rapidly chlorinates the amine to form a 
chloramine. Therefore, the amount of Chloramine / Tyr peptide is equivalent to the amount 
of HOCl added, provided the peptide is available in excess. (B) Differential equations were 
used to solve for the intramolecular rate constant, k1, as described in the Methods section.  
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corresponding to the 95% confidence level. The rate constant values are reported as 
middle value ± ½*range; the middle value was calculated from the high and low SSD 
values that defined the range of certainty (95% confidence level) and were within 1% of 
the optimized value in all cases. 
 
Characterization of Secondary Structure by Circular Dichroism 
 CD samples were prepared by diluting concentrated peptide stock of a known 
concentration into 200 mM phosphate buffer, pH 7.4, to obtain a final concentration of 
200 µM peptide in a cell with a path length of 0.1 cm. The concentration of the stock 
solutions was determined by UV/vis spectroscopy using the molar absorptivity of 
tyrosine (ε275 nm = 1368 M-1cm-1).46 CD spectra were recorded using a JASCO model J720 
spectropolarimeter with a nitrogen flow rate of 5 L/min. Typical spectral accumulation 
parameters were a time constant of 1 sec and a scan rate of 100 nm/min with a 0.5 nm 
step resolution over the range of 195-350 nm with 12 scans averaged for each spectrum. 
The accumulated average spectra were trimmed at a dynode voltage of 700 prior to 
baseline subtraction and smoothing using the reverse Fourier transform procedure in the 
KASCO software. CD spectral values for peptides were expressed in units of residue 
molar ellipticity (deg • cm2 / residue dmol). The temperature of the CD cell was 
equilibrated at each temperature for 15 min prior to acquisition of the spectra. The initial 
temperature was 5 °C and was increased in 10 °C increments to 65 °C. 
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Results 
Spacing of Lysine and Tyrosine Residues Alters Rate of Chlorination 
To examine the effect that the spacing between the chloramine and the NO2Tyr 
residue had on the rate of chlorination, we synthesized peptides with 0-3 residues 
between the lysine and NO2Tyr residues. These peptides were characterized and shown to 
have very similar pKa values around 6.9 and CD spectra analysis showed all peptides 
were unstructured (Appendix G). Each peptide was reacted with HOCl at 37 °C, in 10 
mM phosphate buffer at pH 7.4 to calculate the initial rate of ClNO2Tyr production. The 
reactions were stopped by introducing excess cysteine, which rapidly reacts with lysine 
chloramine at a rate of about 108 M-1s-1,28, 29 and the resulting peptides were quantitated 
by HPLC. The initial reaction kinetics were all independent of peptide concentration and 
first order with respect to HOCl concentration, as seen previously in linear peptides 
containing histidine chloramine and NO2Tyr.
40 The rate constants and pKa values for the 
four peptides containing NO2Tyr used in this study are summarized in Table 1. 
 
CD Spectra of Cyclic Peptide Indicates Gramicidin S Homology 
 The CD spectra of cyclo-P(OH)TKLDFP(OH)TYLDF in aqueous phosphate buffer 
at pH 7.4 was determined at temperature ranging from 5 °C to 65 °C (Figure 3). The 
negative minima around 200 and 220 nm are similar to those exhibited by cyclic 
gramicidin S analogues, as previously reported.44, 49, 50 According to the work of 
Jelokhani-Niaraki et al., gramicidin S analogues with distorted sheet and turn structures 
exhibit more negative ellipticities around 200 nm than 220 nm and vary more with 
temperatures compared to gramicidin S analogues with more stable antiparallel beta- 
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Table 1. Rate Constants for Chlorination of NO2Tyr by Lysine Chloramine within a 
Peptidea 
 
Peptide Sequence 
Residues between 
Lys and NO2Tyr 
Rate Constant (s-1) pKa 
Ac-GNK-Y(NO2)-AE-NH2 0 6.18 ± 0.18 x 10
-5 6.8 ± 0.1 
Ac-GKN-Y(NO2)-AE-NH2 1 7.05 ± 0.22 x 10
-5 6.8 ± 0.1 
Ac-KGN-Y(NO2)-AE-NH2 2 2.54 ± 0.03 x 10
-5 6.9 ± 0.1 
Ac-KGNA-Y(NO2)-E-NH2 3 1.96 ± 0.09 x 10
-5 6.9 ± 0.1 
 
aReactions were performed at 37 ºC, pH 7.4 in 10 mM phosphate buffer. 
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Figure 3: CD Spectra of cyclo-P(OH)TKLDFP(OH)TYLDF. The secondary structure of 
the gramicidin-S analogue, cyclo-P(OH)TKLDFP(OH)TYLDF, was analyzed by CD 
spectroscopy at a concentration of 200 µM in 200 mM phosphate buffer at pH 7.4. The 
arrow indicates the change in the CD spectra as the temperature of the sample was 
increased from 5 °C (bold) to 15, 25, 37, 45, and 65 °C, consecutively. Cooling the 
temperature back to 5 °C indicated no significant change from the initial measurement 
(data not shown).  The large negative ellipticities around 200 and 220 are similar to those 
exhibited by cyclic gramicidin S analogues as previously reported.49  
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sheets which have double minima at 205 and 220 nm with comparable ellipticities and have 
minimal changes in secondary structure with temperature changes.49 Our gramicidin S 
analogue, cyclo-P(OH)TKLDFP(OH)TYLDF, shows characteristics more in common with 
the distorted gramicidin S analogues, though the CD spectra of the peptide at 65 °C has 
minima at 205 and 220 nm that may be consistent with the antiparallel beta-sheets in 
gramicidin S. 
 
Rate of Tyrosine Chlorination by Lysine Chloramine Increased in Cyclic Peptide 
 Approximately 75 µM of the cyclic peptide cyclo-P(OH)TKLDFP(OH)TYLDF 
was reacted with 50 µM HOCl in 10 mM phosphate buffer at pH 7.4 at 37 °C. The 
reaction was stopped by the addition of excess cysteine at varying time points and the 
tyrosine- and 3ClTyr-containing peptides were quantitated by HPLC (Figure 4A). The 
product peak was confirmed to contain 3ClTyr by its UV-spectra and its mass by LC-MS 
(data not shown). The loss of tyrosine-containing peptide and growth of 3ClTyr-
containing peptide were modelled according to our kinetic scheme in Figure 2 and the 
rate constant was determined to be 1.02 x 10-3 s-1 (Figure 4B). 
 
Discussion 
The biomarker 3ClTyr is formed when HOCl, the unique product of MPO, 
chlorinates the phenol ring of tyrosine. HOCl can also chlorinate amino groups on the 
side-chains of lysine or histidine. While it has been postulated previously that the 
chlorination of tyrosine in vivo is through chloramine intermediates, the rate of 
chlorination of free tyrosine by free chloramine is slow.29 Studies have since shown that, 
in proteins, 3ClTyr formation is favored in tyrosine residues that are located near a lysine  
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A. HPLC of cyclo-P(OH)TKLDFP(OH)TYLDF + HOCl 
 
 
B. Kinetics of cyclo-P(OH)TKLDFP(OH)TYLDF + HOCl 
 
 
Figure 4: Kinetics of cyclo-P(OH)TKLDFP(OH)TYLDF Chlorination by HOCl. 75 
µM of the peptide cyclo-P(OH)TKLDFP(OH)TYLDF was reacted with 50 µM HOCl at in 
10 mM phosphate buffer at pH 7.4 at a temperature of 37 °C and the reaction was stopped 
by the addition of excess cysteine at set time points. (A) HPLC was used to monitor the 
decrease of cyclo-P(OH)TKLDFP(OH)TYLDF at and the increase of the chlorinated 
product cyclo-P(OH)TKLDFP(OH)TY(Cl)LDF. This shows the amount of product 
formation after 5 minutes. (B) The concentration of each species was quantitated from the 
UV-HPLC and were modeled to determine the rate constant of chlorination. The solid lines 
represent the modeled reaction progress with an optimized rate constant. The 
intramolecular rate of chlorination in this peptide was determined to be 1.02 x 10-3 s-1. 
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or histidine residue.33, 39 The proposed reason for these increased yields of chlorination is 
that the restriction in freedom between lysine and tyrosine allows the likelihood of their 
collision to increase and favoring their reaction together (Figure 2).37, 40 For example, 
Bergt et al. discovered that tyrosine residues in alpha-helices are preferentially 
chlorinated when in the sequence motif KxxY or KxxxY, where x is a residue that is 
unreactive with HOCl.38 These studies only looked at the yields of 3ClTyr in simple 
systems. In order to be able to predict how likely 3ClTyr formation would be in a more 
complicated system, such as in the human cell where antioxidants are present, we need to 
determine how the rate of chlorination can change with structure. 
To investigate how spacing between lysine and tyrosine can affect the rate of 
chlorination, we synthesized peptides containing a varying amount of residues between 
NO2Tyr and lysine. Chlorination of NO2Tyr by HOCl or choramines has been previously 
determined to follow the same mechanism as chlorination of tyrosine and is 
approximately three-fold slower,40 which allows us to more easily follow the growth of 
chlorinated product over time. The rate constants of these peptides were determined and 
are shown in Table 1. We see that the sequence motif that had the fastest rate of 
chlorination was KxY(NO2), followed by KY(NO2), KxxY(NO2), and KxxxY(NO2), 
respectively. The fastest rate constant was only approximately 3.5-fold faster than the 
slowest in these motifs. The effect of sequence on the intramolecular kinetics of 
chlorination is independent of a defined peptide secondary structure since all peptides 
examined in this report have negligible helical structure as shown by circular dichroism 
spectroscopy (Appendix G). If we were to extrapolate from this model to the 
chlorination of tyrosine and formation of 3ClTyr, the fastest rate of chlorination in the 
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KxY motif would be approximately 2 x 10-4 s-1. Based on previous trends,37, 40 this may 
be enhanced 1000-fold by replacing lysine with histidine, up to a rate of  about 0.2 s-1 in a 
HxY motif. 
Our determination that the KxY(NO2) sequence motif has the fastest rate of 
chlorination seemingly contradicts the previous study that identifies KxxY and KxxxY as 
having the greatest yields of 3ClTyr.38 We believe that this discrepancy lies in the 
secondary structure of the peptides being studied. Bergt et al. were studying peptide 
fragments from apolipoprotein A-I which are known to lie in regions with alpha-helix 
characteristics.51 In an alpha-helical structure, residues that are spaced with two or three 
residues between them appear on the same face of the helix.52, 53 Our own peptides in this 
study were completely unstructured and therefore present only the effect of the amino 
acid sequence on 3ClTyr formation. This suggests that secondary structure may play a 
significant role in the rate of tyrosine chlorination and warrants further investigation. 
 To investigate the role of secondary structure on tyrosine chlorination by HOCl-
induced lysine chloramine, we attempted to synthesize a peptide that restricted lysine and 
tyrosine closely in space to increase the reaction kinetics. Our peptide, cyclo-
P(OH)TKLDFP(OH)TYLDF (Figure 1), was based on the structure of the cyclic 
decapeptide gramicidin S, which is known to have a beta-pleated sheet motif with several 
hydrogen bonds between the parallel strands.41, 42, 54 To verify that our peptide was 
properly cyclized and had the appropriate beta-sheet characteristics, we characterized the 
peptide by LC-MS/MS (Appendix F) and circular dichroism (Figure 3). These studies 
indicated that our peptide was cyclized correctly and had strong homology to gramicidin 
S. These characteristics theoretically favor the intramolecular transfer of chlorine from 
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the lysine chloramine. The kinetic study was performed and the rate constant was 
determined to be 1.02 x 10-3 s-1 (Figure 4). This is about 5-fold faster than the proposed 
rate of chlorination in a KxY motif we extrapolated above. 
 In the human cell, there are a plethora of available reactants for HOCl that 
compete with tyrosine. Reduction of HOCl by antioxidants such as glutathione or the 
sulfur-containing amino acids methionine and glutathione are rapid with rate constants 
ranging from 105 to 108 M-1s-1.28, 31 These are significantly faster than the rate of 
chlorination of tyrosine by HOCl at 71 M-1s-1.37 However, the reaction of HOCl with 
histidine or lysine to form chloramines at 104 to 105 M-1s-1,27, 28 is better able to compete 
with the antioxidants. Furthermore, the accelerated chlorination of tyrosine residues 
nearby histidine or lysine discovered in this study would further increase the incidence of 
3ClTyr formation even in the presence of antioxidants. This evidence suggests that 
chloramines play a significant role in formation of the biomarker 3ClTyr in vivo and that 
the majority of 3ClTyr formed will be protein-bound and will not exist as free amino 
acids. 
 Additionally, the regioselectivity of tyrosine chlorination seen in this study has 
implications in the formation of the 3ClTyr byproduct Cl2Tyr. Several studies have 
shown that concentrations of 3ClTyr in polypeptides will plateau then decrease as 
increasing amount of HOCl are added.33, 55, 56 The loss of 3ClTyr is accounted for if 
Cl2Tyr is concurrently measured.
37 Because the chlorination of 3ClTyr by HOCl or 
chloramines undergoes the same mechanism of chlorination as tyrosine, the same 
regioselectivity applies. In other words, peptide primary or secondary structures that 
position chloramine and tyrosine close together and favor 3ClTyr formation will also 
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favor Cl2Tyr formation. It is our recommendation that any study that measures 3ClTyr to 
correlate it to MPO activity must also measure Cl2Tyr in order to avoid underestimating 
the degree of inflammation. 
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CHAPTER FIVE 
DISCUSSION 
Loss of 3ClTyr and NO2Tyr by HOCl 
3-Chlorotyrosine (3ClTyr) and 3-nitrotyrosine (NO2Tyr) are useful as markers of 
myeloperoxidase (MPO) activity in inflammatory tissue because they are stable and 
readily measurable. Two studies called into question their stability as concentrations of 
these markers decrease upon exposure to hypochlorous acid (HOCl), the unique product 
of MPO.1, 2 If the rate of decrease is sufficiently fast, it would implicate that any previous 
study measuring these markers potentially underestimated the activity of MPO. In our 
study we identify the products of 3ClTyr or NO2Tyr reacting with HOCl and determine 
the kinetics of chlorination, summarized in Figure 1. 
The product of HOCl reacting with 3ClTyr is 3,5-dichlorotyrosine (Cl2Tyr), as 
reported by several previous studies.3-6 The rate constant of chlorination of 3ClTyr was 
determined to be 238 M-1s-1, approximately 3-fold faster than the rate of chlorination of 
tyrosine at 71 M-1s-1. Although the rate constant is greater, there are several orders of 
magnitude more tyrosine than 3ClTyr in a cell; studies in vivo observe 0-1000 µmol of 
3ClTyr per mol of Tyr.7-11 This would suggest that HOCl reacting with 3ClTyr would be 
insignificant. However, in the few studies that measured Cl2Tyr in vivo, the amount 
observed is similar to the amount of 3ClTyr.12-14  
Pattison et al., who had previously overestimated the rate of tyrosine chlorination 
by HOCl,15 have since accepted our determined rate constants.16 They, and others, have 
since used these values to argue that previous studies only measuring 3ClTyr without 
Cl2Tyr may be underestimating the degree of MPO activity.
16-18 We agree with this 
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Figure 1: Products of 3ClTyr and NO2Tyr Reacting with HOCl or Chloramines. N-
acetylated analogues of tyrosine were used in these studies to prevent oxidation of the 
amino-group of tyrosine. Ac3ClTyr, N-acetyl-3-chlorotyrosine; AcCl2Tyr, N-acetyl-
dichlorotyrosine; AcClNO2Tyr, N-acetyl-3-chloro-5-nitrotyrosine; AcNO2Tyr, N-acetyl-
3-nitrotyrosine; AcTyr, N-acetyltyrosine; HOCl, hypochlorous acid; NO2
•, nitrogen 
dioxide; NO2Cl, nitryl chloride. 
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assessment that MPO activity has likely been underestimated. Because of the increased 
rate of 3ClTyr chlorination by HOCl and the high yields of Cl2Tyr observed in vivo, we 
recommend that any future studies that measure 3ClTyr should also measure Cl2Tyr 
simultaneously. 
The product of HOCl reacting with NO2Tyr is 3-chloro-5-nitrotyrosine 
(ClNO2Tyr). The rate of NO2Tyr chlorination by HOCl was determined to be 24.5 M
-1s-1, 
three-fold slower than the chlorination of tyrosine by HOCl. These slower kinetics, 
combined with the fact that regioselectivity of tyrosine chlorination differs from that of 
tyrosine nitration, suggest the ClNO2Tyr formation is likely to be insignificant in vivo.
6, 19 
Furthermore, NO2Tyr formation is not specific to MPO activity; tyrosine can be nitrated 
by peroxynitrite, which is formed with superoxide reacts with nitric oxide independent of 
MPO.20 In fact, one study has determined that tyrosine nitration is predominantly 
mediated in peroxynitrite-dependent pathways in human cells.21 No studies to date have 
tried to measure ClNO2Tyr in vivo and, based on these results, we do not recommend it as 
a future study direction. 
 
Chlorination of Tyrosine by Chloramines 
 Chlorination of tyrosine by HOCl (71 M-1s-1) is much slower than the reduction of 
HOCl by antioxidants such as glutathione (~108 M-1s-1) or sulfur-containing amino acids 
like cysteine and methionine (~107 M-1s-1).15 As such, it has been argued that any 3ClTyr 
measured in vivo only occurs after the oxidation of all available antioxidants.22 One 
proposed alternative explanation is that HOCl-induced chloramines, such as histidine or 
lysine chloramine, are intermediates in the chlorination of tyrosine. This is evidenced by 
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the preferential chlorination of tyrosine on proteins that are nearby histidine or lysine 
residues.5, 6, 23 
 The rates of tyrosine chlorination by histidine and lysine chloramines as free 
amino acids (3 M-1s-1 and 0.004 M-1s-1, respectively) determined in this study are 
significantly slower than direct chlorination of tyrosine by HOCl. This alone cannot 
explain the preferential chlorination of tyrosine near these residues in peptide. However, 
when tyrosine and lysine are constrained in close proximity within a peptide, the rate of 
chlorination increases significantly. Our study of chlorination of the peptide Ac-
KGNYAE-NH2 by HOCl showed an initial velocity (V0) 600-fold greater than an 
analogous amino acid mixture (see Chapter 2, Figure 7). This is likely due to the 
reduced degrees of freedom of the tyrosine and lysine side-chains when they are confined 
to the same peptide. The intermolecular kinetics of tyrosine analogue chlorination by 
HOCl or chloramines are summarized in Table 1. 
 Additionally, lysine chloramine may protect chlorination potential from reduction 
by antioxidants such as glutathione. The fast reaction of HOCl to form lysine chloramine 
(~105 M-1s-1) better competes with the antioxidant glutathione (~108 M-1s-1) than the 
direct chlorination of tyrosine analogues (~102 M-1s-1). The lysine chloramine would then 
be able to undergo intramolecular chlorination of tyrosine prior to reduction by 
glutathione, provided the intramolecular kinetics are sufficiently fast.24, 25 Figure 2 
provides a schematic highlighting the relevant kinetics. 
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Table 1: Summary of Tyrosine Analogue Chlorination as Free Amino Acids. All 
reactions were performed at 37 °C in 100 mM phosphate buffer at pH 7.4. 
 
Chlorinating 
Species 
AcTyr 
(M-1s-1) 
Ac3ClTyr 
(M-1s-1) 
AcCl2Tyr 
(M-1s-1) 
AcNO2Tyr 
(M-1s-1) 
HOCl 71 ± 8 238 ± 27 32 ± 6 24.5 ± 1.2 
HisCl 3.0 ± 0.3 10.4 ± 1.0 1.7 ± 0.2 1.1 ± 0.2 
LysCl 0.004 ± 0.003 0.008 ± 0.002 0.003 ± 0.002 NDa 
 
aNo significant amount of product was detected after two hours of reaction 
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Figure 2: Summary of Reactions by HOCl that Compete with 3ClTyr Formation. All 
rate constants are for individual amino acid analogues. The rate constants for HOCl or 
chloramines reacting with sulfur containing amino acids or glutathione and primary amines 
reacting with HOCl are published elsewhere.15, 26 The remaining rate constants are from 
Table 1. 
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Effect of Peptide Primary Structure on Tyrosine Chlorination by HOCl 
It has been determined previously that tyrosine is preferentially chlorinated by 
HOCl if it is on a peptide and near a lysine or histidine residue.5, 6 Bergt et al. in 
particular created several peptide fragments in an alpha-helical arrangement that 
separated tyrosine from lysine by varying residues.6 They saw that peptides with a KxxY 
or KxxxY motif (where x is a residue unreactive with HOCl) showed the greatest yields 
of 3ClTyr, though the kinetics were not determined. In addition, their observation that 
tyrosine at residue 192 on apolipoprotein A-I was preferentially chlorinated was 
attributed to a KxxY motif, which ignored the fact that histidine on residue 193 also 
contributes to 3ClTyr formation.23 
Our study set out to determine what effect changing the spacing between tyrosine 
and lysine had on the rate of chlorination in a simple, unstructured peptide. Using 
peptides with a varying number of residues between lysine and NO2Y (NO2Y rather than 
tyrosine was used because its slower rate of chlorination and unique UV-spectra assisted 
with analysis), we determined the rate constants of tyrosine chlorination. The effect of 
lysine positioning on the rate of NO2Y chlorination was such that KxY > KY > KxxY > 
KxxxY. The rates of the four peptides studied varied minimally, with the fastest at 7 x 10-
5 s-1 being only 3.5-fold faster than the slowest. Additionally, replacing a lysine residue 
with histidine accelerated the chlorination kinetics 1000-fold more, suggesting that 
histidine chloramine is the more likely cause of 3ClTyr formation at residue 192 of 
apolipoprotein A-I. Table 2 summarizes the kinetics of tyrosine chlorination in the 
peptides we synthesized in these studies. 
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Table 2: Summary of Tyrosine Analogue Chlorination in Peptides. All reactions were 
performed at 37 °C in 10 mM phosphate buffer at pH 7.4. 
  
Peptide Sequence Rate Constant (s-1) 
Ac-HGNY(NO2)AE-NH2 2.60 ± 0.53 x 10
-2 
Ac-GNKY(NO2)AE-NH2 6.18 ± 0.18 x 10
-5 
Ac-GKNY(NO2)AE-NH2 7.05 ± 0.22 x 10
-5 
Ac-KGNY(NO2)AE-NH2 2.54 ± 0.03 x 10
-5 
Ac-KGNAY(NO2)E-NH2 1.96 ± 0.09 x 10
-5 
Ac-KGNYAE-NH2 2.38 ± 0.07 x 10
-4 
cyclo-P(OH)TKLDFP(OH)TYLDF- 1.02 x 10-3 
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Our results demonstrating that the KxY motif is faster than the KxxY or KxxxY 
motifs may appear to contradict what was reported by Bergt et al.6 However, their study 
utilized peptide fragments that were alpha-helical analogues and had even greater alpha- 
helical characteristic while lipid-associated, increasing ClTyr yields.  In an alpha helix, 
the lysine residues would appear on the same face as the tyrosine residues when spaced 
three or four residues away. Additionally, the structure of the apolipoprotein A-I 
fragment they synthesized had its crystal structure analyzed previously, demonstrating 
that the tyrosine and lysine alpha-carbons are only 4.5 Å from each other.27, 28 These 
results suggest that the secondary structure of a protein may be more important to the 
chloramine-induced formation of 3ClTyr than the primary structure, and warranted 
further study. 
 
Effect of Peptide Secondary Structure on Tyrosine Chlorination by HOCl 
 Our final study was to determine how the secondary structure could affect the rate 
of tyrosine chlorination by HOCl-induced chloramines. Ideally, the structure would place 
a chloramine near the tyrosine phenol ring and constrict the degrees of freedom to further 
facilitate chlorination. We synthesized the peptide cyclo-P(OH)TKLDFP(OH)TYLDF 
which is based on gramicidin S, a short peptide known to have a beta-pleated sheet 
motif.29 Beta-turns in this peptide are induced by Pro-DPhe bonds, with the hydrogen 
bonds between the anti-parallel strands further stabilizing the structure.30, 31 We modified 
the structure to include lysine and tyrosine on opposite strands, as well as using hydroxy-
proline and threonine to add hydrophilic characteristics to the peptide, allowing us to 
perform kinetics under the same conditions as our previous studies. CD spectroscopy of 
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this peptide indicated that it was homologous to other gramicidin S analogues and has 
slightly disorganized beta-sheet structure and beta turns as opposed to the anti-parallel 
beta-sheets seen in native gramicidin S (see Chapter 4, Figure 3). 
 We determined the rate of tyrosine chlorination by lysine chloramine in cyclo-
P(OH)TKLDFP(OH)TYLDF to be 1 x 10-3 s-1. This is approximately 5-fold faster than the 
rate of tyrosine chlorination by lysine chloramine in the simple unstructured peptide Ac-
KGNYAE-NH2. While we expected a more significant increase in the rate of 
chlorination, this does support the hypothesis that secondary structure can facilitate an 
increased rate of chlorination of tyrosine by lysine chloramine. Additionally, if we 
extrapolate the difference between AcTyr chlorination by lysine chloramine versus 
histidine chloramine, we expect the intramolecular rate of tyrosine chlorination by 
histidine in a similar cyclic peptide to be 1000-fold greater at 1 s-1. Our kinetic studies 
support the claims of other researchers that propose that formation of 3ClTyr in vivo is 
predominantly facilitated by intramolecular chlorination by chloramines in a peptide.5, 6, 
32 Furthermore, the regioselectivity of specific tyrosine residues in a protein would favor 
further chlorination of the same tyrosine residue, suggesting that measurement of protein-
bound Cl2Tyr may be a relevant marker of inflammation. 
  
Overall Trends in the Kinetics of Chlorination of Tyrosine Analogues 
Table 1 provides a summary of the chlorination of tyrosine analogues from 
Chapters 2 and 3. The rate of direct chlorination of tyrosine is approximately 22-fold 
greater than by histidine chloramine and 21,000-fold greater than by lysine chloramine, 
averaged across all tyrosine analogues. Chlorination of AcTyr across all chlorinating 
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species is approximately 3.4-fold slower than Ac3ClTyr chlorination, 2-fold faster than 
AcCl2Tyr oxidation, and 2.8-fold faster than AcNO2Tyr chlorination. 
In the context of peptides, this trend between the rate of chlorination by histidine 
chloramine and lysine chloramine holds true. Comparing the rate of chlorination of the 
peptides Ac-HGNY(NO2)AE-NH2 and Ac-KGNY(NO2)AE-NH2 (Table 2), there is an 
approximately 1000-fold difference between the rate of chlorination. This is similar to the 
difference between the rates of chlorination of AcTyr, Ac3ClTyr, and AcCl2Tyr by 
histidine and lysine chloramines. 
This same trend does not hold true for the difference between tyrosine and 
NO2Tyr chlorination in lysine-containing peptides. Comparing the rate of chlorination in 
Ac-KGNYAE-NH2 and Ac-KGNY(NO2)AE-NH2 (Table 2) demonstrates that tyrosine is 
chlorinated about 9-fold faster than NO2Tyr. However, as free amino acids, AcTyr is 
chlorinated about 3-fold faster. This discrepancy has several potential explanations. First, 
our peptide reactions used a lower concentration of phosphate buffer than our amino acid 
reactions (10 mM and 100 mM, respectively). If the pH were slightly closer to 8.5, this 
would cause an increase in the rate of tyrosine chlorination and a decrease in the 
chlorination of NO2Tyr (see Chapter 2, Figure 6 and Appendix E). Second, the steric 
effect of the nitro-group on NO2Tyr may affect the secondary structure of the linear 
peptide in ways that unmodified tyrosine would not, such that lysine chloramine had 
easier access to tyrosine to facilitate chlorination. Another possible explanation is 
variance due to human error. 
The third explanation, human error, is the most likely. It may be that we did not 
perform the kinetic study of Ac-KGNYAE-NH2 carefully enough. It was the first peptide 
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we studied and was before we learned that one must be rapidly mixing the reaction 
vessels with stir bars to uniformly distribute HOCl and prevent HOCl from being present 
in excess, both of which lead to HOCl chlorinating tyrosine in a bimolecular reaction. 
Support of this occurring is in the presence of peptide containing Cl2Tyr (see Chapter 2, 
Figure 7) which should be impossible if only an intramolecular reaction between lysine 
chloramine and tyrosine occurred. Before any comparisons can be made in this regard, 
the peptide Ac-KGNYAE-NH2 would need to be resynthesized and the kinetic study 
repeated.  
 
Future Directions 
 First, to prepare our latest study for publication, we intend to further characterize 
the secondary structure of the cyclic peptide by measuring changes in chemical shift 
deviation by NMR versus temperature.33 Further controls may also be added to the study, 
such as determining kinetics of unstructured, linear analogues of our cyclic peptides. It 
would also be of interest to determine whether a histidine analogue of our cyclic peptide 
truly exhibits the 1000-fold increase in kinetics that we expect.  
 Our next goal would be to establish the link between HOCl concentration and the 
amount of 3ClTyr and Cl2Tyr in human cells. Currently, there are no accurate estimates 
of the amount of HOCl in inflamed tissue, though estimates have been made based on the 
capability of neutrophils to generate HOCl over time.34-36 By exposing human cells to 
HOCl and quantitating the amount of 3ClTyr and Cl2Tyr per mol of tyrosine using 
previously established methods,37 we can begin to better correlate these markers to MPO 
activity. Additionally, due to the rapid reduction of reactive species in the cytoplasm, it is 
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thought that significant quantities of HOCl have difficulty making it to the nucleus.38 It 
would be informative to measure 3ClTyr and Cl2Tyr quantities in histones of cells 
exposed to HOCl and compare those to overall levels. 
 Lastly, we would want to take the methods we’ve developed in the previous 
studies and measure the biomarkers 3ClTyr and Cl2Tyr in human samples. We have 
already discussed with clinicians and other researchers the possibility of analyzing serum 
samples of patients with sepsis or of hypoxic newborns to determine the level of MPO 
activity through 3ClTyr and Cl2Tyr measurement. These can be compared to the current 
clinical standards of inflammation such as the erythrocyte sedimentation rate and C-
reactive protein, both of which can have limited sensitivity at early stages of disease and 
are nonspecific.39, 40 The measurement of 3ClTyr in conjunction with Cl2Tyr within 
proteins of the serum may provide us a means of detecting inflammatory states earlier 
than with the current clinical methods and perhaps provide insight into the mechanism of 
pathogenesis. With LC-MS detection of chlorinated tyrosine becoming as sensitive as 
GC-MS methods17, 41 and the growth of LC-MS/MS machines in hospitals capable of 
these measurements,42 we believe that 3ClTyr and Cl2Tyr are promising markers of 
inflammation for the clinical setting.  
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Appendix A: Characterization of Ac-KGNYAE-NH2 Chlorination Products by 
MALDI-TOF. MALDI-TOF was used to identify products of the reaction of Ac-
KGNYAE-NH2 with HOCl. MALDI samples were prepared using the dried-droplet 
method and 2,5-dihydroxybenzoic acid as the matrix. Samples were analyzed in negative-
ion reflectron mode by a Bruker Autoflex MALDI-TOF. The mass-to-charge ratio was 
calibrated using a commercially-available peptide solution containing angiotensin I and II, 
substance P, bombesin, clipped ACTH residues 1-17 and 18-39, and somatostatin. Due to 
the weak signal of these standards in negative-ion mode, we also added the previously 
characterized peptide Ac-KGNYAE-NH2 (MH
- ion at 722.3468 m/z) to the standard mix 
to achieve a more accurate standard curve. This shows the final products when 260 M 
HOCl reacts with 125 M Ac-KGNYAE-NH2 at 37 °C for 1 hr. Peaks at 722.4, 756.8, and 
790.9 m/z correspond to the MH- ions of the peptide containing tyrosine, 3-chlorotyrosine, 
and 3,5-dichlorotyrosine, respectively. Peaks at 718.2, 752.7, and 786.9 m/z correspond to 
the lysine nitrile form of the peptide with tyrosine, 3-chlorotyrosine, and 3,5-
dichlorotyrosine, respectively. 
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Appendix B: GC-MS of Tyr, 3ClTyr, and Cl2Tyr. Approximately 100 µM of the peptide 
Ac-KGNYAE-NH2 was reacted with 50 µM of HOCl at 37 °C and quenched with 
methionine after one hour. An internal standard of isotope-labelled labeled [13C9]Tyr, 
[13C6]3ClTyr, and [
13C9]Cl2Tyr was added and the samples dried down. The peptide was 
then hydrolyzed with HBr and phenol at 120 °C overnight before being dried down again. 
The residues were then derivatized with propanol and heptafluorobutyric anhydride, as 
previously described (Hazen et al., Free Radic Biol Med, 1997. 23(6): 909-916). The 
resulting n-propyl, per-heptafluorobutyric derivatives of Tyr, 3ClTyr, and Cl2Tyr were 
detected using an Agilent 6890N GC/5973N MSD instrument in negative chemical 
ionization mode, as seen in the above figure. Quantitation of the tyrosine residues was 
achieved by creating a standard curve based on the ratios of 417/426, 451/457, and 683/692 
m/z for tyrosine, 3ClTyr, and Cl2Tyr, respectively. The amount of analyte detected using 
this GC-MS method was not significantly different from the amount of analyte calculated 
using our HPLC method described in Chapter 2. 
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Appendix C: Chlorination of Tyrosine Lowers the pKa Value of the Phenol Hydroxyl. 
The curves plot the following function: percent ionized = (100 x 10(pH – pKa)) / (1 + 10(pH – 
pKa)), where the pKa value was fitted to the experimental data. The 100% ionized and 0% 
ionized absorbance values were fitted to the experimental values at 242, 244, and 246 nm 
for N-acetyltyrosine, N-acetyl-3-chlorotyrosine, and N-acetyl-3,5-dichlorotyrosine, 
respectively. The calculated pKa values for N-acetyltyrosine, N-acetyl-3-chlorotyrosine, 
and N-acetyl-3,5-dichlorotyrosine are 9.8, 8.5,  and 6.7, respectively. 
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Appendix D: Chlorination of AcNO2Tyr Lowers the pKa Value of the Phenol 
Hydroxyl. Approximately 300 µM of AcNO2Tyr or AcClNO2Tyr were suspended in 100 
mM phosphate buffer at the indicated pH values and the absorbance was measured by 
UV/Vis spectroscopy. The absorbance at 430 nm for both compounds in 0.1 M NaOH was 
assumed to represent 100% ionized while the absorbance value while in 0.1 M HCl was 
assumed to represent 0% ionized. The curves plot the function, percent ionized = 
(100·10(pH-pKa))/(1+10(pH-pKa)) where the pKa value was optimized to minimize differences 
between the calculated and experimental values. The calculated pKa values for AcNO2Tyr 
and AcClNO2Tyr are 7.1 ± 0.1 and 5.4 ± 0.1, respectively.  
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Appendix E: pH-Dependence of the Apparent Rate Constant of AcNO2Tyr 
Chlorination by HOCl. 750 μM AcNO2Tyr was reacted with 100 μM HOCl at the 
specified pH for 5, 10, 15, 30, 45, and 60 s. The observed rate constant and error was 
obtained by modeling the HPLC results as described in the Experimental Procedures. The 
solid curve models the pH dependence of the apparent rate constant as kx[phenol][HOCl] 
+ ky([phenol][
-OCl] + [phenolate][HOCl]) + kz[phenolate][
-OCl]. The pKa value for 
AcNO2Tyr and HOCl used to calculate the relative concentrations of the acid and conjugate 
base were 7.1 and 7.5, respectively. Due to the similarity in pKa values, it was necessary 
to combine the rate constants of the phenol reacting with HOCl and the phenolate reacting 
with -OCl. The rate constants are kx = 2.9 ± 1.0; ky = 35.6 ± 1.8; and kz = 1.6 ± 0.9 M
-1s-1. 
The preferred species for the chlorination reaction are either the phenol reacting with -OCl 
or the phenolate reacting with HOCl. 
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Peptide Sequence Theoretical Mass (m/z) Actual Mass (m/z) 
LDFP(OH)TYLDF-P(OH)T 1112.6 1112.1 
LDF-P(OH)TKLDFP(OH)T 1077.6 1077.3 
LDFP(OH)TYLDF-P(OH) 1011.5 1011.4 
DFP(OH)TYLDF-P(OH)T 999.5 999.3 
LDF-P(OH)TKLDFP(OH) 976.6 976.4 
DF-P(OH)TKLDFP(OH)T 964.5 964.1 
P(OH)TYLDF-P(OH)T 852.4 852.2 
DF-P(OH)TKLDF 750.4 750.2 
YLDF-P(OH) 537.3 536.9 
 
Appendix F: Confirmation of Cyclic Structure of cyclo-P(OH)TKLDFP(OH)TYLDF- 
by MS/MS. The purified, cyclic peptide, cyclo-P(OH)TKLDFP(OH)TYLDF-, was 
analyzed using a ThermoFinnigan LCQ Deca XP mass spectrometer and confirmed to have 
a mass of 1240.7 m/z. The original linear peptide sequence was NH2-
P(OH)TKLDFP(OH)TYLDF-CO2 and has a mass of 1258.7 m/z. To determine whether 
cyclization occurred between the N-terminal hydroxyproline and the C-terminal 
phenylalanine, we examined the daughter ions of the 1240.7 m/z mass and identified 
peptide sequences that are only possible if the peptide is cyclized appropriately, shown 
below. The results confirm the intended cyclic peptide was synthesized. Theoretical masses 
were determined using the ProteinProspector tool from prospector.ucsf.edu. 
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Appendix G: CD Spectra of Peptides Containing Lysine and NO2Y. Four indicated 
peptides were diluted into 10 mM phosphate buffer at pH 7.4 with a final peptide 
concentration ranging from 270 to 430 µM. The concentration was determined by 
measuring the UV/Vis absorbance at 360 nm of similarly diluted samples in 0.1 M HCl. 
The CD spectrum was measured on a JASCO model J720 spectropolarimeter at 37 ºC with 
samples in a 1 mm-width cell. Data was measured between 200 and 270 nm in 0.5 nm 
increments with 1 nm band width and 1 s dwell time. The CD was converted to ellipticity 
by dividing by the path length, the concentration of the peptide, and the number of residues 
in the peptide. The spectrum of all four peptides is typical of a disordered secondary 
structure. 
-5000
-4000
-3000
-2000
-1000
0
1000
200 210 220 230 240 250 260 270
E
lli
p
ti
c
it
y
 (
d
e
g
•c
m
2
/d
m
o
l)
Wavelength (nm)
Ac-GNKY(NO2)AE-NH2
Ac-GKNY(NO2)AE-NH2
Ac-KGNY(NO2)AE-NH2
Ac-KGNAY(NO2)E-NH2
